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CHAPTER I
INTRODUCTION
Ever since the first clinical case of Gram-negative
bacteremia was described by Brill and Libman in 1899 (19).
septic shock and its research laboratory equivalent, endotoxic shock, have become an increasingly important clinical
as well as experimental problem.

Based on 1974 population

studies. McCabe estimated that there would be 330,000 reported cases of bacteremia with 132,000 deaths within the
United States per year (144).

The mortality rate has re-

mained extremely high, while the incidence of sepsis
and presumably endotoxemia -- has increased over the years
since 1974 (85).

U~ing

currently available statistics (206)

and McCabe's estimates of incidence and mortality (144),
there will be 380,000 cases of sepsis and 150,000 deaths
per year.

In his book The Lives ££

~ ~~

Thomas (202)

states that the presence of bacterial endotoxin in the blood
stream is interpreted as "the very worst of bad news."
2ndotoxin provides a signal to the host of the presence of
overwhelming numbers of Gram-negative bacteria and the response is a fight to the death.

Unfortunately the massive,

"panic-driven" mobilization of the defense only leads to
host's demise.

As Thomas (202) concludes:
1

~~e

are, in

..

~ne

2

effect, at the mercy of our own Pentagons • • •

In spite of

extensive experimental observations, the mechanisms which
lead to the state of circulatory and metabolic collaps~
caused by Gram-negative bacterial endotoxins are net clearly
understood.
Recently, the state of

~etabolic

failure which leads

to severe hypoglycemia and which is accompanied by the state
of circulatory failure has been a major focus.

Siegel (192)

and Duff (42) have proposed that the metabolic changes which
occur during sepsis may underwrite the ensuing circulatory
syndrome during clinical septic shock.

In light of this

concept they propose that extensive monitoring of the metabelie status along with the already accepted monitoring of
circulatory status in septic patients be used as a guide to
treatment and that, indeed, treatment should be aimed at
correcting the disturbed metabolic state rather than merely
supporting the cardiovascular system.

While the profound,

progressive hypoglycemia during endotoxin or septic shock
has been well-documented in a number of species including
dogs and man, the possible relationship between metabolic
and cardiovascular failure has not been fully explored.
The research included in this dissertation examines
the role of hypoglycemia in the development of cardiavascular failure during endotoxin shock in the dog in order
to answer the following questions:

Is hy?oglycemia merely

a parallel manifestation of the underlying endotoxic

3

syndrome, or does hypoglycemia play a causative role in the
development of circulatory failure following endotoxin administration and i f so, in what ways does hypoglycemia contribute to the pathogenesis of cardiovascular failure?
Specifically, the purposes of this dissertation are fourfold:
1) to develop a canine

~odel

for the continuous monitoring

of blood glucose levels for the induction of well-regulated
alterations in the glycemic state -- i.e. a glucose clamp,
and to assess cardiovascular performance;

2) to correlate

hemodynamic events with changes in blood glucose levels
following endotoxin administration;
hypoglycemia

~ ~

3) to evaluate whether

induces changes in cardiovascular per-

formance potentially leading to a state of circulatory shock
and to compare the cardiovascular alterations of hypoglycemia
with those of endotoxicosis;

and 4) to evaluate the possible

synergistic effects of hypoglycemia and endtoxin and conversely the potential beneficial effects of maintenance of
blood glucose -- at either normoglycemic or hyperglycemic
levels -- during shock.

CHAPTER II
LITERATURE REVIEW
Metabolic and Cardiovascular Failure
during-Circulatory Shock
Carbohydrate Dyshomeostasis
during Endotoxin Shock: Alterations
Blood Glucose Levels

1£

Observations on blood glucose levels during shock
date back to Bernard (1877) who reported hyperglycemia following hemorrhage (214).

While such hyperglycemia has been

confirmed by a number of workers (see references 131, 157,
184, 214, 215 for a complete list of references with regard
to studies of blood glucose levels during hemorrhage), it
is evident that this is an early phenomenon and that hypoglycemia is seen following the transition from reversible
to irreversible hemorrhagic shock (41, 214).
responses are variable:

The glycemic

Some animals die in the hypergly-

cemic phase (131) while others show no initial hyperglycemia
and exhibit a continuous fall in blood glucose from the onset of hemorrhage (36).

Zarly hyperglycemia followed by

hypoglycemia has also been described clinically during cardiogenic shock (174).
This biphasic pattern -- early hyperglycemia and late
hypoglycemia -- is also seen during septic and endotoxic

4

5
shock and has been reported in several species (11, 51, 57,

as ) • Many of the early observations on blood glucose during
endotoxin shock were made during experiments on rabbits (25,
1 22, 150, 151, 203, 223). Menten and Manning (150, 151)
were the first to demonstrate early hyperglycemia followed
by hypoglycemia in rabbits using dead bacteria, a crude
endotoxin preparation.

Penner and Klein (171) were the

first to observe the blood glucose changes in dogs following endotoxin administration, but their results were
anecdotal and they did not follow blood glucose through the
late hypoglycemic stage.

Berk and coauthors (9) reoorted

finding two patterns in blood glucose levels in endotoxic
dogs.

One group showed hyperglycemia followed by hypogly-

cemia; the other proceeded immediately into hypoglycemia
with a continuous fall in blood glucose from the onset of
the syndrome.

The results of Berk et al. (9) are similar

to those of Cowley et al. (36) using a hemorrhagic model.
However, neither group of investigators could be certain
they did not miss a hyperglycemic phase with only periodic
measurements of blood glucose.

Hinshaw and coinvestigators

also saw the second pattern of marked

~ypoglycemia

with no

early hyperglycemia in non-surviving endotoxic dogs (100).
Dogs which survived endotoxemia, on the other hand, were
better able to maintain their blood glucose levels.

Wilson

et al. reported a similar correlation between the ability to
maintain glucose levels and survival in septic baboons (217).

6
Carbohydra~e

Hynoglycem~a

-

Dvshomeostasis: Mechanisms Leading to
during Endotoxin Shock

The mechanism of shock-induced alterations in blood
glucose is still a matter of debate, especially with regard
to the development of hypoglycemia during endotoxin shock.
Two mechanisms have been postulated to contribute to the
profound hypoglycemia of endotoxin shock:

1) depression of

hepatic gluconeogenesis -- along with glycogen depletion in
fed animals -- (12, 53, 54, 57, 88, 147) and 2) increased
peripheral glucose utilization (5, 53, 56. 57, 88, 152, 173,
218).

Wolfe, Elahi, and Spitzer (218) have shown a failure

to maintain an elevated level of gluconeogenesis in spite of
the falling blood glucose level.

Thus, while they conclude

otherwise, gluconeogenesis was relatively depressed in their
model since it was not elevated during developing hypcglycemia.

The importance of increased peripheral glucose util-

ization versus decreased hepatic glucose production, probably depends on the stage of endotoxin shock:

increased

peripheral utilization making a greater contribution early
with decreased hepatic glucose production playing an increasing role as the shock syndrome progresses (219).
Kuttner and Spitzer (124) have shown that gluconeogenesis
may, in fact, be elevated during early endotoxicosis.
The question remains how endotoxin causes these
insulin-like effects.

One possible mechanism is a direct

effect of endotoxin on several tissues (notably adipose

tissue and skeletal muscle) to increase glucose oxidation
(107, 110, 180, 197).

While in some cases the direct ef-

fect has been difficult to establish (53, 110), it is generally accepted that endotoxin may have a direct insulinlike effect under at least some conditions.

Since the di-

rect effect has only been established in vitro or in isolated, perfused organ systems it is difficult, however, to
assess whether these effects occur during the endotoxic
syndrome in vivo.
The crux of the debate over the mechanism of endotoxin-induced hypoglycemia centers around the possible
mediation by humoral factors:

What substances are involved

and what are the sources of these mediators?

The stage of

endotoxin shock is also an important consideration in discussing which mediators are involved since different factors may be released at different stages to initiate and
maintain the metabolic events which lead to the progressive
hypoglycemia.

Buchanan and Filkins demonstrated a marked

hyperinsulinemia in rats following endotoxin administration
(23).

Yelich and Filkins have shown with both perfused

livers and pancreata (220) that this hyperinsulinemia is
not due to an alteration in insulin clearance by the liver
(a finding disputed by Cornell (35)), but to a hypersecretory state of the beta-cells of the endocrine pancreas.
The levels of serum insulin decrease late in the endotoxic
rat as the blood glucose level falls (52).

This finding

8

o£ hyperinsulinemia is still disputed by Adeleye and coworkers (1) •

The role of insulin in the development of

endotoxin hypoglycemia in the dog, however, is not well
defined and even more confusing.

Blackard and coinvesti-

gators reported increased insulin secretion only when
endotoxic dogs were given a glucose load (14).

However,

the results which they reported for untreated dogs are
open to an alternative interpretation.

Insulin levels were

not increased above control in the untreated group; on
the other hand, the levels do not decrease as would be
expected in the profoundly hypoglycemic animal until the
very late stages o£ shock immediately preceding death.
This implies that there is at least a functional hyperinsulinemia since insulin secretion did not decrease normally
with the drop in blood glucose.

If insulin secretion was

not properly braked in the face of extreme hypoglycemia,
the pancreas may have been secreting more insulin than it
should for the given blood glucose level -- thus, exacerbating the hypoglycemia.

More recently, Spitzer and

colleagues have described a brief increase in insulin
release which occurs very early after endotoxin administration in the dog (199).

After this early elevation, plasma

insulin levels declined steadily for the remainder of the
course of endotoxin shock in their model.

Other groups

have reported results which conflict with those of Blackard et al. even after a glucose load -- demonstrating

9
instead a hyuoresnonsive state of the endocrine pancreas
( 1 42).

Thus, because it is hard to reconcile these facts,

the possible role of insulin during canine endotoxin· shock
has never been clearly defined.

Yet, the question of

whether there is a hyperinsulinemia in the endotoxic dog
is potentially important.
In addition tc immunoreactive insulin, there may be
one or more non-suppressible insulin-like substances involved in the pathogenesis of endotoxic hypoglycemia.

Even

in control animals non-suppressible insulin-like activity
(NSILA) is 90% or more of the total biological insulinlike activity (222); therefore, i t should not be surprising
that NSILA is a factor in the development of endotoxic
hypoglycemia.

Filkins has recently demonstrated in the

late stages of endotoxicosis in the rat that the NSILA is
indeed elevated (52).

In addition, Filkins has shown that

at least a portion of this rise in NSILA may be due to the
secretion of an insulin-like substance by macrophages (50).
Besides immunoreactive insulin and non-suppressible
insulin like activity, other humoral substances may be
involved in the development of endotoxic hypoglycemia.
Berry and coworkers have found a substance produced by
macrophages which antagonizes the gluconeogenic activity
of glucocorticoids (10, 156).
have shown that

catechola~ines

Pardini, Jones, and Filkins
are depleted from nerve

terminals in the myocardium and spleen during endotoxin

10

shock in the rat (166).

As this may apply to other organs

such as the pancreas and liver, the catecholamine depletion
may .a, ave several important effects on metabolism: First,
the vasoconstriction caused by the excessive neural drive
which leads to the depletion may cause an increased peripheral utilization of glucose because of the limitation on
organ perfusion.

Second, decreased flow of gluconeogenic

substrate to the liver because of increased peripheral
vasoconstriction may also help explain depressed gluconeogenesis.

Third, if catecholamines are depleted from nerve

terminals in the liver, such depletion would lead to loss
of sympathetic support for gluconeogenesis.

Fourth, if

catecholamines are depleted in the endocrine pancreas, one
of the normal brakes on insulin secretion would be released.
While the catecholamine depletion has only been studied in
heart and spleen, this mechanism -- while speculative -- may
be important in the development of endotoxic hypoglycemia.
Another important factor which may mediate the
effect of endotoxin on peripheral glucose utilization is
tissue hypoxia.

It is well-known that hypoxia and ischemia

increase peripheral glucose utilization and it has been
shown that this is a potential mechanism for increasing'
glucose use by skeletal muscle during endotoxin shock (181).
~owever,

a
.J.'

Romanosky et al. (186) have shown that this is not

~ecessary
•

v~~3

,

•

~~ssue.

condition for increased glucose utilization in
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Which tissues are utilizing glucose during endotoxin
shock is another important question.

Some tissues such as

skeletal muscle may be using inordinate amounts of glucose
at the expense of vital organs such as the brain and the
heart.

During endotoxin shock in the rat, Filkins and

Figlewicz (56) have shown increased glucose oxidation by
liver, hemidiaphragm, spleen and epididymal fat pad, but
not in blood, lung, brain, heart, stomach, and kidney.
Raymond and Emerson demonstrated depressed cerebral glucose
utilization in the endotoxic dog (179).

Spitzer and his

colleagues (136, 198) have demonstrated a shift from free
fatty acids to lactate in the myocardium.

Liu, Long, and

Spitzer (137) more recently have examined myocardial glucose utilization in vitro in response to endotoxin in
addition to palmitate and lactate.

ITsing isolated myocytes

from normal dogs, they found that glucose oxidation was
stimulated directly by increasing doses of endotoxin.
While these in vitro data in large part parallel previous
in vivo studies, the relationship between a direct in vitro
effect and the in vivo effect is not clearly established
since it is still possible that other mechanisms come into
play in vivo.

Kuttner, Apantaku, and Schumer (123) showed

changes in glycolytic intermediates in endotoxic rat hearts
which are consistent with increased glycolytic flux, but
they did not oeasure glucose utilization.

These results are

also consistent with the findings of Marchetti et al. (143)
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who demonstrated a slight increase in glucose utilization
in endotoxic dog hearts in vivo.

It has been demonstrated

by several groups of investigators that the major increase
in glucose utilization is seen in skeletal muscle which is
more than 50% of the body mass ( 181 , 186).

While Hinshaw

and coinvestigators (89) demonstrated increased glucose
utilization in leukocytes from endotoxic dogs, it seems
unlikely that blood cells can make a significant contribution to the increased peripheral glucose metabolism.
Sayeed and Murthy (189) demonstrated an approximate doubling
in glucose oxidation of endotoxic lung slices as compared to
control slices.

Overall, the consensus is that the major

glucose utilizer during endotoxin shock is skeletal muscle
with perhaps some minor contribution from fat, lungs, blood
cells, and possibly the

~yocardium,

brain of its necessary fuel.

thus depriving the

Although it has not been ex-

tensively studied, liver may also be an important utilizer
of glucose following endotoxin administration (56).
Su~ma=v

of Carbohydrate
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- t as~s
·
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s·necK,

In summary, following the administration of endotoxin in a number of species -- including the dog -- a
progressive, profound

hypoglyce~ia

develops

~hich

may or

may not be p=eceeded by a brief period of hyperglycemia.
:his hypoglycemia is produced by a depression in heoatic
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gluconeogenesis and increased peripheral utilization of
glucose especially in skeletal muscle brought about by a
direct insulin-like action of endotoxin and by the mediation of hypoxia and ischemia as well as several humoral
factors such as insulin, non-suppressible insulin-like
activity, and glucocorticoid antagonizing factor.
Circulatory Failure:

~

Endotoxic Syndrome

Classically shock is defined as a cardiovascular
syndrome.

This is no less true of endotoxin shock.

The

first systematic studies of the cardiovascular events following endotoxin administration in the dog were those of
Wail and MacLean and their coworkers in 1956 (140, 209).
Following the administration of endotoxin three hemodynamic phases have been described: an initial hypotensive
episode within minutes after bolus injection, a recovery
phase, and a subsequent more prolonged hypotensive phase
culminating in death (30, 67, 157).
tensive episode is

poss~bly

The initial hypo-

caused by the release of

histamines (98, 103, 207) as well as other mediators such
as the endorphins (106, 183) and may well be a systemic
anaphylaxis (140, 196, 209).

The release of these media-

tors leads to dilation in the systemic vasculature, an increase in pulmonary resistance, and a decrease in venous
~eturn

resulting in a decreased cardiac output.

The init-

al hypotension leads to massive sympathoadrenal discharge.
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(S 7 ) with peripheral vasoconstriction and an improvement in

cardiac performance.

Sympathetic outflow, thus, results in

a partial recovery of venous return, cardiac output, and
mean arterial pressure.

There is, however, a second hypo-

tensive phase characterized by a more gradual decline in
blood pressure leading to irreversible shock and death (87).
Early studies of this second phase demonstrated decreases
in both peripheral resistance (61, 87, 95, 104, 209) and
cardiac output (87, 95, 104, 209).

In later studies in-

creases (61, 78, 87) or no change (78, 87) in peripheral
resistance were observed.

The reasons for the discrepancy

noted in peripheral resistance are not fully clear.

Anes-

thesia, species differences, and the conditions of the experiment as well as when and where (i.e. which vascular
beds) the measurements were made may very well make a difference in the response seen.

Regardless of the response,

both peripheral vascular and cardiac mechanisms are involved
in the events which eventually lead to total circulatory
collapse and death.
Cardiovascular Failure during
Shock: ?erioheral Vascular Mechanisms

~ndotoxin

Characteristics of the injuries resulting from endotoxin administration in the dog are the hemorrhagic intestinal lesions first noted by Weiland MacLean (140, 209).
:hese lesions result from splanchnic vasoconstriction,
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increased portal pressure, and hepatosplanchn!c pooling
and congestion (140, 209).

Park, Baum, and Guntheroth

( 167) noted constriction of the portal vein in the dog.
Active venoconstriction in the splanchnic bed following
endotoxin administration was also seen in small mesenteric
and intestinal veins by Meyer and Visscher (153) and Hinshaw and Nelson (99).

While all of these groups obtained

similar results on different veins, Park and colleagues
disputed the concept of splanchnic pooling.

The other

groups felt that vasoconstriction was the mechanism responsible for the splanchnic pooling.
reconciled because Park et al.

This dispute can be

considered pooling in the

splanchnic circulation as a large vein phenomenon instead
of considering the splanchnic circulation as a whole.
Clearly, venoconstriction increases splanchnic venous
pressures and decreases venous volume.

However, venocon-

striction also increases resistance to venous outflow and
pooling will occur in the splanchnic microcirculation.

The

concept of splanchnic pooling is consistent with the
finding of an increased splanchnic blood volume by Chien
et al. (31).

This conclusion is also consistent with the

finding of increased hepatic wedge pressure by Tsargaris,
Gani, and Lange (205).

As a result of splanchnic pooling,

venous return is decreased leading to a decrease in cardiac
output and, thus, perpetuating the shock state.

Splanchnic

pooling along with an overall decrease in splanchnic flow
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leading to severe splanchnic ischemia (77, 135, 165) can
lead to the production and release of cardio- and vasotoxic
materials from the ischemic splanchnic viscera (126, 127).
such toxic materials as the myocardial depressant factor
(MDF) reported by Lefer and coinvestigators (126, 127) may
be the primary mechanism leading to irreversible shock and
death.
Decreases in renal blood flow have been reported
following endotoxin administration in the dog in response
to the systemic hypotension (102).

The decrease in renal

blood flow resulted in a decrease in GFR and urine output
(102).

More recently, using inert gas washout techniques,

Neiberger

~nd

Passmore demonstrated that renal cortical

flow was reduced to a greater extent than renal
flow

i~

the endotoxic dog (160).

~edullary

These investigators also

demonstrated that alpha-adrenergic vasoconstriction plays
a major role in decreased renal cortical flow.

While ini-

tially the decrease in renal blood flow is compensatory for
the systemic hypotension, there are two

i~portant

detri-

mental consequences which result from prolonged renal cortical ischemia:

First, prolonged renal cortical ischemia

and cortical necrosis would ensure that dysfunction is
irreversible.

Even i f blood flow can be restored the kid-

neys would still fail.

Second, relative

~aintenance

wedullary flow would lead to a washout of the

nor~al

~otic

latter

gradient for urine concentration.

T~is

of
os-
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prob 1 em is particularly important since anuria does not
always occur following endotoxin administration (102).
Continued urine flow without the ability to properly concentrate the urine would further exacerbate the shock state.
Vasoconstriction has also been demonstrated in the
skeletal muscle vascular bed following endotoxin administration (181).

As mentioned previously this may contri-

bute to the increase in peripheral glucose utilization and
the end-product of glucose metabolism (e.g. lactate and
hydrogen ions) in turn contribute to the vasoconstriction
in this bed.

Vasoconstriction is largely a compensatory

mechanism, however, to help maintain systemic blood pressure and central blood volume.
Cerebral and coronary blood flow have also been
measured during endotoxin shock.

Myocardial ischemia has

been demonstrated following the administration of endotoxin
in the dog (15, 94, 115).

Blood flow has been shown to

be decreased in several different regions of the brain
following endotoxin administration including several regions involved in cardiovascular and respiratory control
(21, 168, 191).

Altered autonomic control may be an im-

portant mechanism leading to decompensation and irreversible shock and a number of investigators (109, 191, 203)
have postulated that depression of the central nervous
system leading to failure of support of cardiac performance,
peripheral vascular failure, and respiratory depression
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iS a major contributor to the cardiovascular and respiratorY failure of endotoxicosis.

The decrease in blood flow

to the brain is largely due to the fall in blood pressure
since Bryan and Emerson found either unchanged or decreased
resistance in the seven regions which they studied (21).
Parker and Emerson (168) also demonstrated that cerebral
autoregulatory responses were maintained.
Besides the possibility of central nervous system
involvement during endotoxin shock, Trank and Visscher
(204) have shown that cardiovascular afferent systems may
be altered following the
dogs.

ad~inistration

of endotoxin in

Using the isolated carotid sinus technique, these

authors demonstrated higher carotid sinus nerve discharge
frequencies at most pressures following the administration
of endotoxin.

Thus, the baroreceptors were found to be

reset to a hypotensive level following endotoxin injection.
This provides an explanation for the bradycardia and the
variable response of total peripheral resistance during
canine endotoxin shock.

Now the cardiac and peripheral

vascular responses will depend on the difference between
the actual blood pressure and the new set point which is
lower than the control set point.

Paradoxically, then

the baroreceptor reflex could operate to lower the blood
pressure through decreases in heart rate and contractility
and decreases in peripheral resistance as the blood pressure rises back toward control levels.

Halinen (74) has
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demonstrated that other cardiovascular afferent systems,
particularly atrial receptors and the aortic arch baroreceptors, are also depressed during endotoxin shock.

Thus,

cardiovascular control may be upset following endotoxin administration for two reasons:

1) depression of the central

nervous system and 2) resetting of baroreceptors and atrial
volume receptors.

In addition to these events in the sys-

temic vascular beds, there is a maintained elevation in
pulmonary vascular resistance throughout the course of endotoxin shock (87).
Along with the effects of endotoxin on systemic and
pulmonary resistance and their neural control, endotoxin
has been shorNn to cause an increase in capillary permeability in a number of vascular beds including the skeletal
muscle, pulmonary, and splanchnic beds (32, 33, 194).
Increased vascular permeability leads to a loss of fluid to
the extravascular space and a consequent decrease in blood
volume, thus, aggravating the shock syndrome.

Zndotoxin

also triggers both classic and the alternate complement
activation pathways as well as both the intrinsic and extrinsic coagulation pathNays (158).

These reactions lead

to disseminated intravascular coagulation, increases in
vascular permeability, and host defense reactions which
cause tissue injury and decreased tissue perfusion.
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C rdiovascular Failure during
E~dotoxin Shock: ~ ~ 2£ ~ Heart

-

The role of cardiac failure in the decompensatory
phase of circulatory shock is often debated.

Classically,

it has been presumed that the function of the heart as
~ell

as the brain is preserved during circulatory shock or

only secondarily fails late in the course of shock as a
result of peripheral vascular failure (72, 86, 87, 95,
209).

Early studies during endotoxin shock pointed to

decreased venous return (101) as the major cause of decreased cardiac output during the initial phases of endotoxicosis and showed the heart to be resistant to the
detrimental effects of endotoxin during the early stages.

(93, 97).

The evidence of Solis and Downing (193), based

on ventricular function curves in endotoxic cats, however,
pointed to the potential for very early myocardial failure
(within the first two hours).

A large body of evidence in

the endotoxin literature now points to the importance of
early direct myocardial injury leading to cardiac failure.
necently Hess et al. (80) have attempted to systematically

-

study the determinants of cardiac Performance
in endotoxic
...
dogs: heart rate, preload, afterload, and myocardial con'

tractility.

They found increased afterload (as assessed

by total peripheral resistance), decreased preload (as
assessed by pulmonary capillary wedge pressure), and

21

decreased cont~actility (as assessed by stroke work along
with no change in heart rate in their model).

When animals

were given a femoral artery-to-vein shunt. myocardial performance was improved along with preload and afterload
(i.e. left ventricular filling pressure was increased
while total peripheral resistance was decreased).

While

the methods may be somewhat crude. this study serves to
point out that myocardial performance after endotoxin is
affected both by changes in the extrinsic factors of preload and afterload -- i.e. peripheral vascular mechanisms
-- and by an intrinsic depression of the ability of the
myocardium to contract.

\

Two aspects of cardiac performance are altered following endotoxin injection:
2) contractility.

1) heart rate and rhythm and

Most studies have emphasized the de-

pression in myocardial contractility, however, the heart
rate and rhythm disturbances may be as important.

Levy

and Blattberg (133) describe some important effects of
endotoxin on heart rate depending on anesthesia.

In un-

anesthetized dogs they found a triphasic change in heart
rate:

a transient tachycardia, followed by bradycardia and

then a secondary tachycardia.

In dogs anesthetized with

pentobarbital there was a similar initial tachycardia followed by a prolonged bradycardia, while in

~orphine-chlor-

alose-urethane anesthetized dogs there was an initial
tachycardia over a somewhat longer period than in the other
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two groups followed by a return of heart rate to control
levels and then a second

accelerati~n

in heart rate.

They

discussed the role of reflex activation of the sympathetic
versus activation of cardiac vagal fibers in determining
the heart rate under the various anesthetic conditions
following endotoxin injection.

Of particular interest is

the paradoxical bradycardia seen during endotoxin shock.
While the mechanism of this bradycardia is incompletely
understood, it has drastic consequences for the maintenace
of cardiac output following endotoxin administration.

As

mentioned before, the resetting of various cardiovascular
receptors may play a role.

More recent studies have shown

that an unidentified serum factor may be involved in altering cardiac electrophysiology during endotoxin or
septic shock (27, 28).

Recently, Pellet et al. (169) have

demonstrated increased effective refractory periods, increased conduction times (as measured

wi~h

His bundle re-

cordings) and bradycardia along with increased sino-atrial
node recovery times after an extrastimulus in endotoxic
dogs.

These results imply depressed automaticity of the

sinoatrial node and depressed conduction during canine
endotoxicosis.

The authors speculatively discuss the

possible role of depressed responses to

sy~pathetic

stim-

ulation and of myocardial depressant factor in producing
these effects.

However, they do not present data oer-

taining to these potential mechanisms.
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:.fyocardial ischemia has been demonstrated during
endotoxin shock (15, 94, 115).

Thus, one would expect

that all of the myriad effects of myocardial ischemia

~n

myocardial performance -- including dysrhythmias and depressed contractility -- occur following endotoxin administration.

While a number of investigators have demon-

strated a coronary flow deficit during

endotox~n

shock

there remains, surprisingly, some debate as to the effects
of this flow deficit on myocardial function.
et al.

While Bohs

(15) found a biphasic increase in coronary vas-

cular resistance and a decrease in coronary flow they were
unable to get an improvement in myocardial function after
increasing· coronary flo•N" with dipyridamole.

Thus, while

demonstrating the presence of myocardial ischemia during
endotoxin shock, these investigators provide some evidence
that myocardial depression may not simply be due to the
ischemic process.

Other factors may be involved.

On the

other hand, dipyridamole has been shown to be ineffective
during angina pectoris since it merely causes a redistribution of flow rather than improving flow to ischemic
regions --the so-called coronary steal phenomenon (40).
The results of Bohs et al. (15) also conflict with those
of Peyton et al. (172) who found significant improvement
in myocardial function following treatment with sodium
nitroprusside which lowers left ventricular afterload thus
decreasing the left ventricular oxygen demand relative to
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the supply (40).

Hess and various coinvestigators (115,

118 , 120) have shown dysfunction of sarcoplasmic reticulum
calcium uptake and myofibri:lar ATPase which is greater in
the subendocardium than in the subepicardium.

This is con-

sistent with a global ischemic process and the greater subendocardial flow deficit which occurs under these conditions.
These investigators also presented microscopic evidence of
differential subendocardial injury.

Other studies from

this same laboratory (20, 81, 195) found that maintenance
of venous return protected against myocardial failure following the administration of endotoxin.

Hess and his

colleagues concluded that the maintenance of venous return
with a bypass pump or via a femoral artery-to-vein shunt
resulted in a maintenance of coronary blood flow.

Coronary

blood flow, however, was not measured in these studies and
other explanations for improved myocardial performance
during maintained venous return experiments are possible.
In studies with retrograde perfused canine hearts where
myocardial blood flow was artificially maintained, Elkins
et al. (44) also found improved myocardial function.
Improved function was also associated with increased coranary flow in studies of the effects of glucose and insulin
on myocardial performance in endotoxic dogs (4, 90).

In

these studies, however, the effect of the treatment could
not conclusively be attributed to an improvement in blood
flow.
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Another major hypothesis for· the deficit in myocardial performance following endotoxin injection is the toxic
£actor theory principally espoused by Lefer and associates
( 70 , 126, 127).

Lefer and colleagues have discovered a

myocardial depressant factor (MDF) which is produced from
proteins released into the blood stream from the ischemic
pancreas during shock and acted upon by lysosomal hydrolases
from the liver to form MDF (49, 128, 129).

This serum fac-

tor has been shown to depress the contraction of isolated

.oaoillary
.

muscle strips (126, 130) and to be transferable

to non-shocked animals (185).

This theory is consistent

with the results reported by McCaig and Parratt (145) who
found depressed inotropic responses. to calcium administration in vivo but not in vitro.

In another study,

~cCaig

et

al. (146) could find no in vitro physiological or ultrastructural evidence of myocardial depression in isolated
atria or papillary muscle taken from cats 2.5 hours after
endotoxin administration.

This is again consistent with

the idea that a serum factor causes the endotoxic myocardial
dysfunction rather than intrinsic damage to the heart.
Other investigators have not been able to demonstrate a
myocardial depressant factor (96).

In addition, shock

still occurs following endotoxin injection in eviscerated
dogs (173).

Thus, while the evidence for a toxic factor is

fairly strong, the possible role of MDF in the pathogenesis
of endotoxic cardiac failure has been questioned.
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In addition to a possible toxic factor other humoral
agents may be involved in the pathogenesis of myocardial
failure during endotcxicosis.

Recently Reynolds et al·.

( 1 83) have demonstrated improved myocardial function as
assessed by maximum left ventricular dP/dt as well as increased survival following treatment of endotoxic dogs with
naloxone.

Thus, negative inotropic effects of endogenous

opioids may play a role in the development of endotoxic
cardiac failure.

Another potential humoral mediator of

endotoxic cardiac failure is histamine.

Krause and Hess

(119) demonstrated an improvement in the ability of myofibrillar ATPase to hydrolyze ATP following treatment with
diphenhydramine, an antihistamine.

Another study of the

same laboratory showed a beneficial effect of diphenhydra~ine

on the uptake of calcium by sarcoplasmic reticulum

in endotoxic myocardium (79).

While this evidence for

histamine involvement is very indirect, and really inccnelusive in the absence of data showing that histamine depresses myocardial function in either control or endotoxic
hearts, i t nevertheless points to a potential mechanism
for endotoxic myocardial failure.
?ulmonary resistance is increased throughout the
course of endotoxin shock (87).

The afterload to right

ventricular ejection is, thus, increased.

,.,.,.

.

.

. . n.:s .:s a

classical mechanism leading to right heart failure.

...,.

.

"

.:.'1l.gn

rigit ventricular afterload, thus, undoubtedly, contributes
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to endotoxic cardiac failure.
Another aspect of endotoxic myocardial failure may
invclve the response to positive inotropic stimuli.

Areher

and coinvestigators (6) found depressed responsiveness to

infused epinephrine as assessed by maximum negative and
positive left ventricular dP/dt, and myocardial power and
efficiency.

A depression in the coronary blood flow re-

sponse to catecholamines was also demonstrated in this same
study, thus, potentially exacerbating the myocardial ischemia.

A similar depression in the response to norepi-

.

nenhrine has recently been demonstrated by Lust et al. (138) •
These decreases in responsiveness are in addition to the
previously mentioned depletion of myocardial norepinephrine
late in endotoxin shock demonstrated by Pardini and his
coinvestigators (166).
ninshaw (84) has also suggested that disturbances
in myocardial calcium and potassium may contribute to the
myocardial failure.

Another contribution to the endotoxic

cardiac failure may be the mitochondrial swelling, disruption of the contractile

ele~ents

with intracellular

edema, and the increase in extracellular fluid in the
myocardial interstitium which have been reported in the
endotoxic heart (34, 91, 92, 149).
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diovascular Failure during
Summary

~~otoxin Shock:

-

Both peripheral vascular collapse and cardiac failure ha ve been shown to contribute to endotoxic circulatory
collapse. An overall increase in total peripheral resistance is seen which may or may not be maintained over the
entire time course of shock.

Specific increases in re-

sistance have been reported in the splanchnic circulation
where pooling and congestion leading to hemorrhagic intestinal lesions which are pathognomic of endotoxin shock in
the dog.

Arteriolar constriction in the splanchnic bed

may lead to the production of cardia- and vasotoxic materials which are released during an autoregulatory
in the splanchnic vasculature.
show~

escap~

Resistance has also been

to increase in the kidneys where renal cortical is-

chemia and an imbalance between cortical and medullary
blood flow have detrimental consequences for survival, and
in skeletal muscle where ischemia contributes to the increase in peripheral glucose utilization.

3lood flow to

the brain and heart haYe also been shown to be decreased
following endotoxin administration.

~ardiovascular

re-

flexes are depressed as a result of central nervous system
depression and by resetting of baroreceptors and atrial
volume receptors.

Several mechanisms contribute to endo-

toxic cardiac failure:

Ischemia, myocardial depressant
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endogenous ooioids, histamine, altered sympathetic

fa,C tor '

•

nses, increased afterload to right ventricular ejecres.Po
tion, myocardial edema, and altered myocardial calcium· and
potassium have all been postulated to contribute to this
failure.

None of these postulated mechanisms is mutually

exclusive and several or all of them may contribute to the
myocardial failure seen after endotoxin injection.

The

exact mechanism is still in dispute.
Early Studies

£!

~ RelationshiP
Circulatory Failure
Following Endotoxin Administration

.£! Hetabolic

~

Several groups of investigators have examined the
effects of glucose infusion during endotoxin or septic
shock.

In 1975, Weisul et al. (211) studied the beneficial

effects of glucose, insulin, and potassium solutions in
patients with sepsis and speculated on the potential role
of hypoglycemia in the myocardial lesions of clinical septic
shock.

Berk et al. (9) found significant improvement in

the survival of endotoxic dogs following glucose administration except at the higher doses of endotoxin studied.
These authors also found differences in blood pressure
based on whether the dogs went through an early hyperglycemic phase.

Hinshaw and coworkers (100) demonstrated im-

proved survival in the dog when glucose levels were maintained at oreshock levels, and, in addition, found a positive correlation between the ability of an animal to
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. tain. o~lucose homeostasis and survival -- only three out
of eleven animals surviving endotoxic administration with-

ma~n

out glucose treatment.
by Wilson et al.

Similar results have been obtained

(217) in the baboon.

Hinshaw's studies

( 1 oo), however, in contrast to the results of Berk (9),
demonstrated protection even at the relatively high dose of
endotoxin used in this study (LD 70 ). Hinshaw et al. (90)
and Archer et al. (4), however, were unable to demonstrate
a protective effect of glucose on the endotoxic myocardium,
but these results were obtained using a donor perfused dog
heart model in which myocardial failure could not always be
demonstrated following endotoxin administration (84).
Spitzer, Wagner, and Blackard (200) also have published
data which is consistent with a beneficial effect of glucose
treat~ent

-- showing improvement in mean arterial pressure,

heart rate, and cardiac output in dogs receiving an LD 70
dose of endotoxin and glucose treatment. These authors
also found significant hyperinsulinemia following glucose
infusion in endotoxic dogs.

This explains both the lack of

any increased 24 hr survival in this study since all infusions were stopped after 5 hrs and provides a potential
explanation for the differences in the results of the Hinshaw experiments (100) and the Berk (9) studies -- at the
higher doses of endotoxin in the Berk studies the animals
may have become significantly hyperinsulinemic so that following glucose treatments the dogs became hypoglycemic
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leading to the death of the animals.
The bulk of the data in these studies consists of
survival data.

Thus, it is not clear what the mechani"sm

for increased survival is.

It seems likely that mainte-

nance of blood glucose levels during endotoxin shock will

be beneficial whether or not glucose dyshomeostasis plays
a causative role in the demise of the animal or whether it

is merely symptomatic of the overall cardiovascular and

metabolic failure.

More importantly, the technology for

continuous blood glucose monitoring and thus for maintenance
of controlled alterations in the glycemic state was not
available until recently.

The glucose clamping experiments

included in this dissertation are based on new techniques
and are appropriate to provide more definitive evidence for
the role of hypoglycemia in the pathogenesis of circulatory
failure following endotoxin administration.

While the idea

that hypoglycemia plays an important role in the development
of circulatory failure during shock is not new -- Carl
Wiggers speculated on this point in his classic monograph
(214) -- and while several studies have lent credence to
this concept, none are '.vholly conclusi're.

Furthermore, the

site of action of the protective effects of glucose and presumably the detrimental effects of hypoglycemia has not
been clearly established.

CHAPTER III
EXPERIMENTAL DESIGN AND RATIONALE
Two sets of experiments were designed to study the
role of glucose dyshomeostasis in the develpoment of cardiovascular failure during endotoxin shock.

The first ma-

jor set of experiments entailed the measurement of various
cardiovascular parameters (see section on cardiovascular
measurements in Chapter IV - Methods) along with glucose,
insulin, and lactate without any interventions to alter
blood glucose in order to correlate the changes in blood
glucose with the depression of cardiovascular function
during endotoxin shock.

The second major set of experi-

ments was an attempt to alter the pattern of the cardiovascular events of endotoxin shock by controlling blood glucase -- at hypoglycemic, normoglycemic, and hyperglycemic
levels -- using a "glucose clamping" technique.

If glucose

dyshomeostasis plays a critical role in the development of
circulatory failure, then 1) development of metabolic failure must precede development of circulatory failure (or at
least the critical events of metabolic failure must precede
the critical events in the development of cardiovascular
failure) and 2) altering the pattern of metabolic failure
by controlling the blood glucose levels should lead to a
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detectable alteration in the development of cardiovascular
failure.
To test the aforementioned hypothesis four types of
experiments were performed: 1) unclamped, 2) hypoglycemic
clamped, 3) hyperglycemic clamped, and 4) normoglycemic
clamped.

In each experiment one group of dogs received

saline after the appropriate control period and the other
group of dogs received endotoxin.

The endotoxin injected

dogs were followed until their death from endotoxin shock
up to a maximum of 10 hrs.

The saline injected dogs pro-

vided a time-matched series of control dogs which were
followed for a period equal to cr exceeding the maximum
time of survival of the corresponding endotoxic dogs.
Relationshiu £f Hemodynamic ~vents
to Metabolic Events during Endotoxin
Shock -- Unclamned Studies
The first major set of experiments in which no interventions were made allowed the assessment of the time relationships of the events of metabolic and cardiovascular
failure during canine endotoxicosis.

While all of the in-

dividual measurements made in this set of experiments have
been made previously by others and published, without continuous glucose monitoring it has not been possible to make
this type of correlation.

Furthermore, the presence or

absence of an early hyperglycemic phase and the relationship of such a phase to the development of circulatory
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failure could not be conclusively demonstrated ~ithout continuous blood glucose monitoring. Thus, this first set of
experiments is

imp~rtant

for determining the sequence· of

metabolic and vascular events.
Cardiovascular Function in the Endotoxic
during Altered Glycemrc-states
Glucose Clamoing Studies

~

The primary purpose of the glucose clamping experiments was to alter blood glucose concentration in order to
determine whether such an alteration changes the pattern of
cardiovascular events in the endotoxic dog.

If development

of glucose dyshomeostasis plays a critical role in the development of circulatory shock (even if it is not the only
factor), then clamping the glucose at different levels -hypoglycemic, normoglycemic, and hyperglycemic -- should
cause a change in the pattern of development of circulatory
shock:

glucose deprivation would be detrimental to the

maintenance of circulatory function, while maintenance of
glucose supplies would be beneficial.

Thus, glucose

clamping should lead to predictable alterations in cardiovascular performance and survival in the endotoxic dog.
A secondary purpose of glucose clamping was to study
the insulin responsivity and glucose utilization rates of
endotoxic dogs.

The question of insulin responsivity in

endotoxicosis is an important and

~uch

debated question.

The technique of glucose clamping -- at hyp~rglycemic and
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lycemic levels -- has been used by DeFronzo, Tobin,
norm Og
and Andres (38) to measure glucose utilization and insulin
responsivity in humans.

If this technique could be adapted

to the endotoxic dog in combination with continuous glucose
monitoring, it would help to answer this important question.
In the DeFronzo technique (38) the hyperglycemic
clamp provides an index of the beta-cell response to glucose
while the normoglycemic clamp provides an index of tissue
insulin responsivity.

The measured parameters in this tech-

nique are blood glucose, serum insulin, and the rates of
glucose and insulin infusion.

In the hyperglycemic clamp,

the infusion rate of glucose reflects glucose utilized after
correcting for the error between thd desired clamp level and
the actual blood glucose level -- i.e. the glucose utilized
will be greater than or less than the glucose infused depending on whether the actual blood glucose is less than or
greater than the desired glucose level.

This error can be

corrected for with knowledge of the glucose space and of
the urinary excretion of glucose during the clamp.

The

hyperglycemic clamp can also be used to determine the tissue responsivity to endogenous insulin levels using the
ratio of glucose utilized to the peripheral insulin level.
In the normoglycemic clamp, as developed by DeFronzo
(38), insulin is infused at a constant rate sufficient to
raise the serum insulin levels significantly above normal.
Glucose is then infused at the rate needed to maintain
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normoglycemia.

Again the glucose infused is converted to

glucose utilized in response to the insulin load.

In nor-

moglycemic clamps the glucose utilized reflects the tissue
responsivity to exogenous insulin.

In addition, the meta-

bolic clearance rate of insulin can be determined by dividing the insulin infusion rate by the difference between
the basal insulin concentration and the concentration during the infusion.

The adaptability of this technique to

the endotoxic dog is dependent on two factors:

First, that

endogenous glucose production is negligible during glucose
infusions, and second, that the glucose space does not
change significantly during endotoxin shock.

It is poss-

ible that neither of these factors is negligible in the endotoxic animal, but it is nevertheless worthwhile attempting
to adapt this technique to the endotoxic dog since it provides a simple way of studying tissue insulin responsivity,
beta-cell glucose responsiveness, and peripheral glucose
utilization in the intact animal.

CHAPTER IV
METHODS
Exnerimental Grouns
A total of 46 dogs were included in these experiments.

Another 28 dogs were excluded from the study be-

cause of difficulties in completing the protocol or in tolerating the instrumentation procedures.

The 46 dogs inclu-

ded in these studies were divided into 8 groups:
clamped saline-treated

contra~

dogs (N=5),

1) un-

2) unclamped

3) saline-treated hypogly-

endotoxin-treated dogs (N=16),
cemic-clamped dogs (N=5),

4) endotoxin-treated hypogly-

cemic-clamped dogs (N=6),

5) saline-treated hyperglycemic-

clamped dogs (N=3),

6) endotoxin-treated hyperglycemic-

clamped dogs (N=4),

7) saline-treated normoglycemic-clamped

dogs (N=3), and
dogs (N=4).

8) endotoxin-treated normoglycemic-clamped

Specific protocols are discussed in the fol-

lor,ving section.
Endotoxin Prenaration
Escherichia coli endotoxin (055:35), prepared by Difco (Detroit, MI) using the Boivin method, was used in this
study.

The same batch of endotoxin (controi number 6555468)

was utilized in all experiments to provide for consistent
37
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potency throughout the study.
in

o.9%

The endotoxin was suspended

saline to a concentration of 5 mg endotoxin/ml.

Every dog received the same weight-adjusted volume of endotoxin or vehicle.

The endotoxin dose of 8 mg/kg was chosen

to provide a very high lethality (100%) over a 10 hr period
in untreated dogs.

Using this dose of endotoxin (in a total

of 53 dogs given endotoxin and undergoing at least part of
one of the four protocols) one dog succumbed during the initial hypotensive phase and one additional dog died during
the early hyperglycemic phase.

Also two dogs died during

the glucose clamping phase of the hypoglycemic clamp experiment and one during the clamping phase of the hyperglycemic
clamp experiment.

Thus, while 8 mg/kg is a high dose of

endotoxin, most dogs went through the usual pattern of
events -- the only real effect of this high dose being to
shorten the time course so that the blood sampling needed
for the various measurements could be made without compromising the ability of the animals to survive.
Canine Model
Mongrel dogs of either sex weighing 18.9±0.5 kg
(X±S.E.M., range 14.5-26 kg, N=46) were used in this study.

All dogs were kept in the animal facilities for at least one
week prior to their experimental use.

Dogs were fed (Pu-

rina Dog Chow) midmorning every day through the day prior
to the acute experiment.

Dogs were also free of any
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obvious

sio~ns

of infection such as mucous discharge from the

nose or diarrhea prior to the acute experiment. When neeessary, dogs were given a course of penicillin or other
appropriate antibiotics to treat an existing infection and
observed to be outwardly symptom-free prior to their experimental use.

Thus, although the previous infectious his-

tory was highly variable and largely unknown, all dogs were
in apparent good health at the time of experimentation.

All dogs were routinely given a prophylactic course of
tetracycline antibiotics and were treated for intestinal
parasites.

In addition all dogs were vaccinated against

rabies, canine distemper, and parvo virus.
Initial Surgical Procedures
Food was withheld from all dogs for the 24 hrs prior
to the acute experiment

(i.e~

they were last fed on the

morning of the previous day).

During this period of time

all dogs continued to receive water ad libitum.

Dogs were

anesthetized intravenously via the cephalic vein of the
forelimb with sodium pentobarbital (NEMBUTAL, 30 mg/kg).
This dose was supplemented with J-4 mg/kg every 1-1.5 hrs
during the experiment to maintain a level of anesthesia
(see (69) for dosage schedule).

In order to minimize the

cardiovascular depressant effects of pentobarbital
especially in endotoxic dogs -- these supplemental doses
were diluted to 10 ml with saline so that they could be
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slowly over a 3-5 min period. In spite of this pregiven
caution. twelve endotoxic dogs died during anesthetic supplementation partway through a protocol.

Data from those

dogs which died during anesthetic supplementation were excluded from analysis.
Following initial anesthetization a tracheotomy was
performed.

All dogs were then intubated with a glass or

plastic Y-tube and allowed to breathe on room air spontaneously.

Both femoral veins were cannulated to allow for

intravenous infusions and for simultaneous venous sampling.
The right femoral artery was cannulated for withdrawal of
arterial samples for the measurement of arterial blood gases
and pH.

Arterial P02, PC02, pH and bicarbonate were mea-

sured in blood samples obtained every 15 min during control
periods and every 30 min during experimental periods using
a Corning 165/2 semi-automatic blood gas and pH analyzer.
The blood gas analyzer was calibrated daily with standard
buffers of pH 6.838 and 7.382 and with calibration gases
containing 12% 02, 5% C02• balance nitrogen and O% 0 2
C02, balance nitrogen.

,

10%

The ambient barometric pressure was

checked daily and the percentage compositions were con?erted
to partial pressures assuming a body temperature of J7°C
and saturation with water vapor (vapor pressure at 37°C,
47 mmHg).

The calibration gases are bubbled through sep-

arate humidifier bottles to saturate the gases prior to
entering the sample chamber.

The calibration for both oH
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and blood gases (oxygen and carbon dioxide) was checked
periodically throughout the experiment and remained relatively stable (pH: ±0.005 units and oxygen and carbon dioxide: ±2 mmHg).

If the calibration drifted outside these

specified ranges the instrument was recalibrated.

Rectal

temperature was monitored in all dogs with a YSI thermistor
probe.

As body temperature can significantly affect meta-

bolic variables, this temperature was maintained between 36
and 39°C with a heating pad and by covering the animal uith
surgical drapes during the experiment.
Cardiovascular Instrumentation
Electrocardiogram
All recordings were made on a Grass model 7
channel polygraph.

eig~t

A lead II electrocardiogram was rou-

tinely recorded using needle electrodes in the skin of both
hindlimbs and the right forelimb.

This lead was chosen to

provide reasonably large upright QRS complexes.

Heart rate

was counted using fast traces of the electrocardiogram
taken every fifteen minutes.
Left Ventricular Performance
and Svstemic Arterial Pressure
A Millar catheter-tip transducer (model PC 470) was
introduced via the left femoral artery and positioned in
the left ventricle for the measurement of left ventricular
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pressure.

The pressure wave form was used as the sole

guide in proper placement of this transducer.

Occasionally

a ventricular dysrhythmia was induced during the placement
o£ the Millar catheter.

Such dysrhythmias could usually be

suppressed by manipulating the catheter within the ventricle
or in some cases by treating with lidocaine as necessary
( 1-2 mg/kg i v).

In any case no animal was used for exper-

imentation in which the presence of a dysrhythmia or the
treatment necessary to suppress it compromised ventricular
performance as assessed by left ventricular pressure, dP/dt,
cardiac output, and systemic blood pressure.

Two dogs died

of ventricular fibrillation after placement of this catheter
and three additional dogs could not be used due to the presence of ventricular tachycardia which persisted in spite
of treatment even after the catheter was removed from the
ventricle.
This transducer provides a good frequency response
(0 to 20 KHz) and avoids the problems of fluid-filled catheter systems.

There is less than 1 mmHg/hr drift; thus,

over the course of a 10 hr experiment there is less than
10 mmHg drift.

The catheter could be placed during an

acute experiment without opening the chest and without
requiring prior chronic implantation as with some other
intravascular transducers.
The signal from this transducer was electronically
differentiated and recorded on an adjacent cnannel,

The

43

differential could then be used as a marker of end-diastole
on fast traces so that
sured.

end-diasto~ic

pressure could be mea-

In some cases a Millar catheter with a second· trans-

ducer placed 4 em behind the tip (Model PC 770) was used
allowing the simultaneous recording of systemic blood
pressure from the root of the aorta.

This method of mea-

surement of systemic blood pressure was useful since a
check on valve performance was provided.

However, this

particular catheter could not be used in every case since
blind

place~ent

using only the pressure as a guide is more

difficult due to the smaller diameter of the distal catheter segment and the greater flexibility of the material
that this segment is made of.

In most cases the single

transducer catheter was used and systemic blood pressure
was measured from the catheter in the right femoral artery
using a Statham P23ID transducer.
Left ventricular stroke work was calculated from
the peak left ventricular pressure, the cardiac output
(see the following section), and the heart rate using the
following formula:
Left Ventricular Stroke Work= LVP x (C.O./HR)
where, LVP = peak systolic pressure
c.o. = cardiac output
HR = heart rate

(1)

3ecause of the frequency response characteristic of the
Grass model 7 recorder dP/dt cannot accurately be measured.

44
In the present study dP/dt was used only for timing of
cardiac events because of this limitation of the recorder.
Thus, stroke work was used instead to quantify cardiacperformance.

Both dP/dt and stroke work, however, suffer

from the problem of being sensitive to preload, afterload,
and heart rate as well as myocardial contractility.

Thus,

with either index it is difficult to separate peripheral
vascular and cardiac events.

Both indices have been used

to assess cardiac performance during endotoxin shock.
However, caution must be used in concluding that a cardiac
mechanism is involved.
The Measurement of Cardiac Cutout
and ~ Pulmonary Artery Pressure
A number seven French Swan-Ganz balloon catheter
(110 em in length) for the measurement of mean pulmonary
artery pressure and cardiac output was introduced into the
right external jugular vein and guided through. the right
side of the heart and into the pulmonary artery using the
pressure wave form.
~edged

The catheter was inserted until it was

with the balloon fully inflated; after which the

balloon was deflated and the catheter was secured in place.
Visual inspection on post-mortem examination has demonstrated that the tip was then in one of the major branches
of the pulmonary artery.

Numerous studies by Edwards

Laboratories have shewn that the trans-cardiac loop of

45

catheter can either shorten or lengthen depending on changes
in cardiac performance and warming of the body of the catheter to blood temperature -- thus. either wedging the·tip
of the catheter or allowing it to fall back into the right
ventricle.

Thus, it was necessary to periodically readjust

the position of the catheter when mean pulmonary pressure
could no longer be measured at the tip (either because it
was wedged or because the tip had moved back into the right
ventricle as determined by the pressure record).

In some

dogs a few ventricular premature beats were seen during the
passage of the catheter through the right heart.

Inflation

of the balloon whenever the catheter was in the right ventricle minimized dysrhythmias since floating the catheter
tip tended to keep the catheter away from the ventricular
wall.

The soft material with which this catheter is made

and the brief excursion through the right side of the heart
also tended to minimize the occurrence of dysrhythmias.
Cardiac output was measured every fifteen minutes
throughout the experiment using the thermodilution technique
(see (132) for a good recent review of the thermodilution
technique).

Cardiac output was converted to cardiac index

by dividing cardiac output by the surface area of the dog
which was calculated on the basis of weight with the formula
appropriate for the weight range of dogs used in this experiment:

S.A.

= 0.114

2j3

x W · (13, 75:

note that the con-

atant 0.114 is the average of the two values given in the
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references).

The appropriate mean arterial pressure is

divided by the cardiac index to determine the systemic and
pulmonar Y vascular resistance (the venous pressure for.
both beds is assumed to be 0 for this calculation).

The

average of 3-5 serial measurements of cardiac output made
at the end of each fifteen minute period is reported.

With

each measurement 3 ml of ice-cold 0.9% saline were injected
as rapidly as possible into the proximal port (nominal volume 0.92 ml) of the Swan-Ganz catheter.

This port is lo-

cated 30 em behind the tip of the catheter and when the
catheter is properly placed it lies in the superior vena
cava proximal to the right atrium.

This positioning allows

for adequate mixing before reaching the pulmonary artery.
Care was always taken to inject during the same part of the
respiratory cycle (end-inspiration)

this is especially

important in the dog because of the large azygous vein
drainage in this species which is intermittent during the
respiratory cycle.

Care was also taken to minimize syringe

handling prior to injection in order to avoid significant
warming of the injectate.

The temperature change is de-

tected by a thermistor embedded in the catheter 4 em behind
the distal port at the tip.

This thermistor is connected

to an Sdwards model 9520A cardiac output computer which
performs the necessary calculations to obtain cardiac output in liters per minute.

A second thermistor used to mon-

itor the temperature of the injectate bath is also connected
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cardiac output computer. Both bath temperature and
to •he
~
blood temperature can also be displayed by the cardiac output computer.
The thermodilution technique is essentially an indicator-dilution technique in which temperature rather than
concentration is used to determine the distribution of the
indicator.

The temperature detected by the thermistor in

the pulmonary artery is dependent on the properties of heat
exchange between the ice-cold saline injectate and the blood
and surrounding tissues.

These properties in turn are de-

pendent on the heat capacity of saline and blood and the
rate of blood flow past the thermistor.

Since the heat

capacities are a constant and known quantity, the temperature will vary according to the rate of flow past this
thermistor

~-

i.e. at high rates of flow heat exchange is

more rapid and the temperature change will be smaller while
at low flow rates the "cold" injectate is carried away less
rapidly and the temperature change is consequently larger
and more prolonged.

The mathematical derivation of this

property is the following equation:
(2)

flow

=
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where,

Pr

= density

of injectate

= heat

capacity of injectate

60

= seconds/minute

= correction

for temperature change prior
to injection

= injected

volume (corrected for residual
volume of catheter

= blood

temperature

= injectate
= density
= heat

temperature

of blood

capacity of blood

integral of thermodilution
curve
The terms which do not include temperature are all constant
and are combined to form a calibration constant which is
dialed into the cardiac output computer prior to use.

For

3 ml of ice-cold saline the calibration constant calculated
by ~dwards Laboratories after numerous trials is 0.132 for

the model 9520A cardiac output computer.

This constant is

reasonably accurate for injectate temperatures in the range
0-5°C.

Blood and injectate temperatures are continuously

stored prior to injection and the cardiac output computer
uses the values stored just prior to starting the integration in the calculation of the cardiac output.

The Edwards
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computer calculates an analog integration of the thermodilution curve which is automatically terminated at the point
where the curve returns to 30% of its peak.

This cuts-off

approximately 22% of the area which is compensated for mathematically in the calculation of cardiac output by electronically multiplying the integral by 1.22.

This cutoff point

was chosen experimentally by Edwards Laboratories as being
the point of minimum variability in the downslope of the
curve.

Beyond this point there is a release of heat from

the heart and blood vessel walls which distorts the tail
end of the curve.

This is not, however, true recirculation

which does not occur in the thermodilution technique.
Several factors influence the reproducibility and
accuracy of the measurement of cardiac output by the thermodilution method.

First, the volume and temperature of the

injectate are important variables (16, 48).

The greater

the volume and the lower the temperature of the injectate
(i.e. the greater the difference in temperature between
blood and the injectate) the greater is the signal-to-noise
ratio.

Thus, high volume, low temperature injectates have

the best signal-to-noise ratios:

nowever, the cold temp-

erature and the high volume can also affect cardiac output
by altering heart rate and contractile force.

Therefore,

it was necessary to compromise in these experiments by
using the smallest allowable volume (3

~l)

of ice-cold

saline minimizing the problem of the volume of injection
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(vhich may be a very important consideration under the low
cardiac output, high pulmonary resistance state of endotoxin shock) while giving a reasonable signal-to-noise
ratio.

This does not, however, mitigate the problem of the

rapid injection of ice-cold saline into the right atrium on
the SA node or on AV nodal conduction.

The continuous mon-

itoring of the EGG and of hemodynamic parameters during injection provided some check on this problem.
A second factor is the speed of injection (45, 60,
62).

All injections should be made smoothly and rapidly

(Edwards Laboratories requires a speed no slower than 4
ml/sec (26)).

Injections which are too slow or not made at

a uniform speed will not give true cardiac output readings.
Reasonable care in making injections and attention
to the factors which may affect cardiac output measurement
by this technique results in measurements which correlate
very

~ell

with those made by the Fick principle (16) or

with electromagnetic flow probes (169).

Using either can-

nulating electromagnetic probes or periaortic probes, Pelletier and associates (169) obtained correlation coefficients
of 0.98 and 0.96, respectively, with the thermodilution
technique using ice-cold injectates in dogs (?<0.001) in
100 or more determinations.

All of these determinations

were made in control dogs under steady-state conditions.
This raises one other consideration:

During circulatory

shock the cardiac output is no longer in a steady-state.
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There may be wide variations over a short period of time
resu 1 •4n~
..,.... o in differences between serial measurements of
greater than

5% and occasionally greater than

10%.

·While

thiS may make individual measurements less accurate it is
likely that trends over long periods of time will still be
accurately reflected and that differences in the pattern
between groups will still be faithfully recorded.

Thus,

the technique is still a useful tool even with the loss of
accuracy under non-steady state conditions and has been
found to be useful in critically ill patients under those
conditions (45).

Thus, thermodilution cardiac outputs are

used to provide an index of flow in these experiments without having to open the chest either acutely or during prior
surgery to implant an electromagnetic flow meter.
Summary
To summarize, the following cardiovascular parameters
are measured or calculated:

Lead II electrocardiogram,

heart rate, left ventricular pressure, left ventricular
dP/dt, left ventricular stroke work, cardiac output, cardiac index,

pul~onary

artery pressure, systemic arterial

pressure, and systemic and pulmonary vascular resistance
(calculated from the mean systemic and pulmonary arterial
pressures and the cardiac index).
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~·fetabolic

-

Metabolic Measurements:

Mea.su=ements

Glucose

Glucose was measured using the YSI model 26 Cantinuous Glucose Monitor.

This instrument combines the elec-

tronics for the measurement of blood glucose by the glucose
oxidase method with a peristaltic pump for the continuous
withdrawal of the sample.

Blood is withdrawn via a double

lumen catheter which adds a small amount of heparin and
sodium fluoride (both of which have been shown by Yellow
Springs Instruments not to interfere with the glucose oxidase measurement (221)) via one lumen while the blood is
being withdrawn via the other lumen at the rate of 2, 5, or
10 ml/hr.

The cannula for blood glucose sampling is placed

by venipuncture in the left external jugular vein.

Using

this method of withdrawal there is no systemic anticoagulation of the animal and there is only a slight dilution
of the sample from this source which is controlled for by
calibration using the same catheter system.

Throughout most

of the experiment the pump is on the slowest rate of withdrawal so that only minimal volumes of blood are withdrawn
for the measurement of glucose.

During glucose clamping

the 10 ml/hr speed is used to provide for better resolution
of any changes in glucose level with time.

The pump also

introduces an appropriate amount of buf:er into the sample
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chamber to dilute the sample and to maintain pH for the glucose oxidase reaction.
~lutaraldehyde
d

Glucose oxidase is immobilized on a

resin membrane.

This layer is sandwiched

between a polycarbonate membrane on the outside facing the
sample chamber with a pore size large enough to readily
pass glucose, oxygen, and hydrogen peroxide, water, and
salts and a cellulose acetate membrane on the inside facing
the electrode with a pore size that excludes glucose, ascorbic acid, and most interfering substances but which permits the passage of hydrogen peroxide, water, and salts.
The buffer also contains excess amounts of catalase to destray any back-diffusing hydrogen peroxide.

During the

glucose oxidase reaction glucose combines with oxygen to
form gluconic acid and hydrogen peroxide.

The hydrogen

peroxide then can diffuse across the inside of the membrane to the electrode.

At the electrode the hydrogen per-

oxide is oxidized creating a current which is proportional
to the amount of hydrogen peroxide present in solution.
Since hydrogen peroxide is produced in the glucose oxidase
reaction in stoichiometric proportion to glucose consumed,
the current is also related to the amount of glucose in the
sample.

Thus, the monitor can -- using appropriate cali-

bration (buffer -- i.e. 0 mg/dl -- and a 200 mg/dl standard
were used for calibration and a nominal 500 mg/dl standard
for a linearity check) -- then translate this current into
glucose concentration in mg/dl.

This method correlates well
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~ith

other methods of measuring blood glucose (108).

-

Metabolic Measurements:

Insulin

Using the radioimmunoassay technique, insulin was
measured in serum samples taken every 15 min throughout
the experiment from a catheter in the right femoral vein.
Pharmacia Diagnostics Phadebas Insulin kits were used for
this measurement.

In this assay anti-insulin antibodies

are immobilized on Sephadex beads.

The radioimmunoassay

technique employs the displacement of iodine-125 insulin
from the antibodies by non-radioactive insulin from the
sample.

This displacement occurs in a stoichiometric man-

ner such that the greater the insulin concentration in the
sample the greater the amount of radiolabelled insulin which
is displaced.

The antibodies and any bound insulin are

immobilized on Sephadex beads which can be
the supernatant solution.

sepa~ated

from

The remaining bound radioac-

tivity is quantified using a gamma counter.

The counts

obtained can then be related to the amount of insulin in
the sample using appropriate standards to form a standard
curve.

?or these experiments the standard curve and the

samples are analyzed using a computer program developed
by Kober and Yelich (see Appendix B) for the digital PDP
12 computer utilizing a log-logit type analysis.

Data is

entered into the computer from the gamma counter using a
paper type reader.

The log-logit analysis Nas shown to
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give values which correlate very well with those obtained
bY reading off of the standard curve by hand.

Correlation

coefficients for the log-legit plots made by the computer
were usually greater than 0.98 demonstrating the appropriateness of the log-legit linearization technique.· Standard
points which were off of the standard curve could be
removed from the fit using an error correcting routine
within the program.

'rtlhen the 0 uU/ml standard (H 0

was

)

less than 15% of the total activity the kits no longer gave
good results and the results were not used.

The H0 standard

for brand new kits was usually about 25% of the total activity.

This assay method has been shown by this laboratory

to give reasonably good results with rat insulin (221).
In addition, Pharmacia reports within and between assay coefficients of variation of approximately 5 to 10 per cent
using human control sera.

Initially the results with dog

serum samples were found to be reasonable as well •. However,
during the course of this study it has been discovered that
under certain conditions spuriously high results may be obtained (fasting control samples in the range of 100's to
1000's of uiT/ml).

Since others have had a similar problem

(personal communication with Nancy Manson), this does not
seem to be an isolated instance and may be a factor in the
wide variability in the literature of the reported insulin
levels in the endotoxic dog (14, 142, 198).

,.,

~!le

•

l

..

~n-cerure~.~a-

tion of the insulin results included in this dissertation
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must, therefore, be made with a great deal of caution.
This problem will be discussed further, where appropriate
in the results and discussion sections.

-Metabolic Measurements:

Lactate

Deproteinized whole blood lactate samples obtained
every fifteen minutes (from the right femoral vein) were
precipitated in 0.8% perchloric acid (0.5 ml of sample in
1 ml of perchloric acid).

The samples were then centrifuged

to obtain the supernatant and lactate was determined with
the Calbiochem-Behring Rapid Lactate kits using an enzymatic method.

Samples were pooled into control (prior to

endotoxin or saline injection), early (first half of time
course) and late shock (second half of time course) samples
for unclamped endotoxic dogs, and into postinjection clamp

(15-120 min) and post clamp (135 min-termination of the
experiment) samples for glucose clamped dogs.

The assay

method uses lactate dehydrogenase isolated from beef heart
to convert the lactate to pyruvate while NAD is reduced to
HADH.

The reaction is driven to completion by adding glu-

tamate and glutamate-pyruvate transaminase to the reaction
mixture.

Thus, the pyruvate which is produced from lactate

is converted to 1-alanine in the transamination reaction.
The NADH absorbs light in the ultraviolet range at 340 nm.
The NADH produced and consequently the lactate consumed can
thus be determined by measuring the UV absorbance of the
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samples after the reaction is driven to completion (60 min
at J0°C).

The reaction is buffered in pH 9.5 TRIS buffer.

All samples were run in duplicate and an average of the
two absorbance readings was taken as the reported values.
The lactate concentration in the diluted samples is calculated from the linear regression of a standard curve
using the following standards (run singly with each assay):
1) 0.44 mM, 2) 1.10 mH, 3) 2.20 mM, 4) 3.30 mM, and 5) 4.40
mM.

The linear regression and the calculation of sample

concentrations including corrections of the concentration
for the dilution of the original sample were performed on
an HP97 calculator using a curve fitting program obtained
from the Hewlett-Packard statistics package for the HP67/97.
Summary
To summarize the metabolic variables:

Whole blood

glucose, serum insulin, and deproteinized whole blood lactate were measured as indices of the carbohydrate status.
Arterial blood gases and pH were also measured in samples
taken from the right femoral artery.
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Protocols
Relationshin 2£ Hemodynamic Events i£
4etabolic Events during Endotoxin Shock
trnclamned Studies
Following a 30 min control period in which measurements were taken every 15 min (i.e. three control measurements were taken) the animals were given either saline or
endotoxin.

All dogs were then monitored for 10 hrs or

until death in the endotoxin group with measurements being
made at the previously stated intervals.

No other inter-

ventions were made in this set of unclamped experiments.
Cardiovascular Function in the Endotoxic ~ during
Altered Glycemic States
Glucose Clamning Studies:
ill Hyuoglycemic Clamu
After 30 min control period all animals were given
an intravenous bolus dose of insulin consisting of the follor,.;ing c·omponents:

80 U/kg of regular insulin, 18 U/kg

LENTE insulin, and 9 U/kg ULTRALENTE insulin.

An infusion

via the left femoral vein was also started at this time at
2

~1/min

of 5 U/ml of regular insulin.

This infusion was

maintained at this rate until the desired level of blood
After 45 min the blood glucose had
..... ,
dropped to 27±2 mg/dl. At this time dogs were given e~~.ner

glucose was reached.

saline or 8 mg/kg endotoxin.

The blood glucose was then

maintained at a mean level between 10 and 30 mg/dl (19.7
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mg/dl) for a period of 2 hrs with intermittent infu-

sions of 5 U/:nl regular i-nsulin at 2 ml/min or 5% glucose
(glucose was given on an empirical basis -- usually 10•20
ml were given over a period of about a minute) as needed.
These doses and infusion rates of insulin and glucose were
chosen by trial-and-error in order to reach and maintain
the desired level of blood glucose.

Because the hypo-

glycemic clamp places considerable stress on the animal and
consequently leads to powerful reflexes to return the blood
glucose back to normal, even these doses of insulin proved
inadequate in some animals to maintain the clamp -- particularly over the first hour of the clamp in endotoxic
animals.

Dogs (N=5) in which the clamp could not be main-

tained for 2 hrs were excluded from the study.

After the

2 hr period all animals were monitored for an additional

3 hrs or until death without further infusions.
Cardiovascular Function iQ ~ Endotoxic ~ during
Altered Glycemic States -- Glucose Clamning Studies:
~ llormo.glycemic Clamn
After a 30 min control period an infusion of 5 U/ml
regular insulin was started at a rate of 1 ml/min along with
an infusion of 50% glucose at a rate of 1 ml/min (both infusions were given through a catheter in the left femoral
Vein).

These infusions were then periodically adjusted by

trial-and-error to maintain blood glucose at a mean level
between 75 and 95 mg/dl (85±1 mg/dl).

After 45 min the
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dose of saline or endotoxin was administered as described
previously.

The clamp was maintained for 2 hrs posteno-

toxin or saline injection after which all infusions were
stopped.

All dogs were then monitored for another 6 hrs

after ending the clamp or until death in the endotoxic
group.
cardiovascular Function
Altered Glycemic States
The Hv-oerglycemic Cla:n-o

-

~ ~

Endotoxic Dog during
Glucose Clamning Studies:

Following a 30 min control period animals were given
a bolus dose of 300 mg/kg glucose (20% glucose in water).
At the same time an infusion via the left femoral vein of
50% glucose was started at 1 ml/oin.

The infusion rate was

adjusted periodically to maintain blood glucose at a mean
level between 145 and 165 mg/dl (156±3 mg/dl);

these ad-

justments were made by trial-and-error to achieve the desired level of blood glucose.

Infusions were maintained

over the same period of time as for the hypoglycemic clamp.
Forty-five minutes after giving the bolus dose of glucose,
animals were given either saline or 8 mg/kg endotoxin.

T~e

clamp was maintained for 2 hrs after the injection of saline
or endotoxin and then all infusions were stopped and the
dogs were monitored for an additional 8 hrs or until death.
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Analysis

In the unclamped experiments data were divided into
a control and a post injection period.

Because of the var-

iable time course of endotoxin shock, the post-injection or
post-saline injection time course was normalized as a percentage of the time to death or the end of the experiment in
the unclamped groups.

This normalization device allowed the

comparison of animals in what is assumed to be similar pathophysiological states.

The data points obtained from the

normalization procedure were then used for statistical comparisons.

Statistical comparison between groups in the un-

clamped experiments was made using a factorial analysis of
variance.

Significant differences between groups were iden-

tified using a modified t-test at the various points.
In the glucose clamping experiments data were grouped
into a control (-75 to -45 -- i.e. prior to any experimental manipulations), a preinjection clamp (0 min-- i.e.
after the glucose clamp is established but prior to saline
or endotoxin injection),
mi~

a postinjection clamp (15 to 120

-- i.e. during glucose clamping after the injection of

saline or endotoxin), and a postclamp period (>120 min
i.e. after the infusions are stopped).

Data from each dog

were averaged over each period of time and the

resulta~t

means were taken as representative data points for each
tim.e period.

l1easurements taken just prior to tne end

62
o£ the experiment were also compared (for some parameters
such as systemic and pulmonary resistance this was not done
since some or all of the animals in the endotoxin groups
died during the course of the experiment).

Statistical

comparisons were made using a one-way analysis of variance
to determine the effect of the three clamps in saline and
endotoxin injected animals.

Significant differences be-

tween groups were identified using a modified t-test.

CHAPTER V
RESULTS

!£!

Unclamped Experiments

A total of 21 dogs, 5 saline-injected and 16 endotoxin-injected, were used in this set of experiments.

As

can be seen from figure 1, the endotoxic group can be divided into a group of 6 dogs which showed an early hyperglycemic phase and a group of 10 dogs which showed no hyperglycemic phase during continuous blood glucose monitoring.
While such an arbitrary division can perhaps be made using
other criteria, glucose is the parameter of interest in
this study and, thus, it is of interest to make the division
in this case based on differences in the pattern of glucose
dyshomeostasis following the administration of endotoxin.
This difference in the pattern of changes in blood glucose
is readily apparent in the records of the individual animals
(see Appendis A, fig. 20) and it is therefore easy to make
this kind of division of the endotoxic dogs into two groups.
Statistical analysis clearly demonstrates that all three
groups of dogs (control and the two endotoxic groups) had
different patterns of blood glucose levels (?<0.05).

The

peak glucose level in the hyperglycemic group of 114±10
mg/dl occurred at 40±5 min following the administration of
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Fig. 1.

Glucose -- Unclamned Exneriments: Saline
( 0, N=5), Endot;xin w~hyper~lycemia (X, N=6),
Endotoxin w/no hyperglycemia (~, N=10). All
three groups exhibit different patterns of
blood glucose (P<0.05).

120100-

-=a
'-..

80--

tn

E
C))
t/)

60--

0
0

~ 40--

r--r-----r---~-r---1

c

10

20

30

40

50

1

60

70

80

% OF TIME TO TERMINAnON

1

90 100

66
endotoxin (at approximately 10 per cent of the average time
course of 398±72 min in the hyperglycemic, endotoxin group
of dogs).

The mean time of survival of endotoxic dogs-not

showing any hyperglycemic stage was 276±47 min.

Using an

unpaired t-test this is not significantly different from
the hyperglycemic group although the trend is toward shorter survival times (t=1.3874 with 14 degrees of freedom,
p:0.094).

This probably is a reflection of the highly

lethal model of endotoxin shock used in these experiments.
Near death, both groups of endotoxic dogs were profoundly
hypoglycemic (10±4 mg/dl in dogs exhibiting an initial
hyperglycemic phase and 9±3 mg/dl in dogs showing no hyperglycemia).

In contrast glucose was fairly well maintained

over a 10 hr period in dogs given saline.
The serum immunoreactive insulin levels are shown in
figure 2.

There were no significant differences in insulin

levels between any of the three groups at any point.
There was a high degree of animal-to-animal variability in
the endotoxic groups as demonstrated by the large standard
errors in these two groups (see also fig. 21, Appendix A).
This high degree of variability probably reflects the highly
variable time course of changes in insulin levels seen in
endotoxic animals.

These results are indicative of at least

a functional hyperinsulinemia in the endotoxic dog.

These

results, however, must be viewed with a certain amount of
caution in light of the previously mentioned problem with
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Fig. 2.

Insulin -- Unclamped Experiments: Saline
( 0, N=5), Endotoxin w/hyper~lycemia (X, N=6),
Endotoxin w/no hyperglycemia l6, N=10).
No significant differences between groups.
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spuriously high insulin levels obtained in other experiments
(see results of glucose clamping experiments).

The fasting

control level of 27±6 uU/ml obtained with this group of 21
dogs is certainly reasonable and while the elevations seen
in some cases following the administration of endotoxin are
dramatic (highest individual insulin measurement: 300 uU/ml)
none of the measured control

they are not unreasonable

or experimental values in the unclamped series of dogs was
higher than the highest standard concentration, in contrast
to the results in the glucose clamping experiments.

Because

of the problem encountered in assaying the samples from the
glucose clamping experiments, these results in unclamped
animals cannot be taken as conclusive proof of hyperinsulinemia in the endotoxic dog.
Tables I, II, and III show the arterial blqod gas and
pH data for the unclamped experiments while the plasma lactate data is included in Table VIII along with the lactate
data from the glucose clamping experiments.

No consistent

changes in either arterial P02 or PC0 2 were seen in either
group of endotoxic dogs.

Both groups of endotoxic dogs be-

came acidotic, but there was no difference in the degree of
acidosis seen in either group.

Lactate was elevated in the

9 endotoxic dogs in this group in which these measurements
were made.

Insufficient samples, however, were taken from

dogs showing hyperglycemia (N=2) to make a comparison of
lactate levels in the two endotoxic groups.

The similarity

Table I Arterial pH -- Unclamped Studies

Late 1

Control
Saline
( 5) 2

7.39±0.03

Endotoxin
l-t/hyperglycemia
(4)2

7.39±0.03

7.09±0.06 4

Endotoxin
no hyperglycemia
(8)2

1:

Early= 0-25% of postinjection time course, Mid= 25-75%, Late= 75-100%

2:

(N)

3:

N=17 for Control

4:

Significantly different from saline, P<0.05

'l'able I I Arterial P02
P02

Saline
( 5) 2

--

Unclamped Experiments

~mmllg)
1

1

Control

Early

85 ±4 3

77 ±2 It

74±3 ..

63±10 4

57 ±11

Endotoxin
u/hyperglycemia

Mid

Late

1

71 ±4 It

It

(4)2

Endotoxin
no hyperglycemia
(8)2

1:

Early= 0-25% of postinjectlon time course, Mid= 25-75%, Late= 75-100%

2:

( N)

3:
4:

N=17 for control measurement
No significant differences

55±9 4

'I'able I I I Arterial PC02

--

Unclamped Experiments

PC0 2 (mmHg)

Saline
( 5) 2

Late

1

33 ±1 ..

30±2 ..

29 ±1

It

39±4 It

42±4 ..

47±5 ..

27±2 ..

30±6 ..

36±4 ..

Early

33 ±2 3

Endotoxin
w/hyperglycemia
( 4)

Mid 1

Control

1

2

Endotoxin
no hyperglycemia
(8)2

1:

Early- 0-25% of postinjection time course, Mid= 25-75%, Late= 75-100%

2:

( N)

3:
4:

N=17 for Control
No significant differences
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of pH in these dogs, however, is an indication that these
levels would probably not be different.
Cardiac output is plotted in figure 3.

The cardiac

output fell rapidly after the administration of endotoxin
and remained below control levels throughout the time course
of shock in both groups of endotoxic dogs.

The cardiac out-

out in endotoxic dogs going through an early hyperglycemic

...

phase tended to be higher than that seen in endotoxic dogs
with no early sign of hyperglycemia.

However, both groups

of endotoxic dogs gradually approached the same end-point.
Both peak left ventricular systolic and end-diastolic
pressures are plotted in figure- 4.

While peak pressure was

below control in both"endotoxic groups throughout the time
course of shock, there were no differences between the two
groups of endotoxic dogs.

However, end-diastolic pressure

fell to a greater extent in animals which demonstrated an
early hyperglycemic phase.
Stroke work is shown in figure 5.

Stroke work was

markedly depressed below control levels throughout the
course of endotoxin shock in both groups of endotoxic dogs.
Following a pattern similar to that for cardiac output,
dogs which showed no hyperglycemia performed significantly
less cardiac work than did dogs which went through an
initial hyperglycemic phase.
~fean

systemic blood pressure is shown in -+'1.· :t'U,.."'
'=>
--

and calculated total peripheral resistance is shown in

o~"
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Fig. ).

Cardiac Output -- Unclamped Experiments:
Saline ( 0, N=5), Endotoxin w/hyperglycemia
(X, N=5), Endotoxin w/no hyperglycemia
(~, N=10).
0 P<0.05 compared to control;
P<0.05 compared to control and endotox
w/hyperglycemia;
0 P<0.05 compared to
control, P<0.1 comnared endotoxin
w/hyperglycemia. •
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Fig. 4.

Left Ventricular Peak Systolic and
End-diastolic Pressures -- Unclamped
Experiments: Saline ( 0, N=5), Endotoxin
w/hyperglycemia (X, N=6), Endotoxin w/no
hyperglycemia (~, N=10). Peak systol~c
pressure -- endotoxin groups less than
control, no differences between endotoxin
groups. End-diastolic pressure -- endotoxin
groups less than control, endotoxin
w/hyperglycemia less than endotoxin w/no
hyperglycemia.
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Fig. 5.

Left Ventricular Stroke Work -- Unclamped
Experiments: Saline ( 0, N=5), Endotoxin
w/hyperglycemia (X, N=5), Endotoxin w/no
hyperglycemia(~, N=10).*P<0.05 compared
to control;*P<0.05 compared to control and
endotoxin w/hyperglycemia;OP<0.05 compared
to control, ?<0.1 compared endotoxin
w/hyperglycemia.
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Fig. 6.

Mean Systemic Arterial Pressure -- Unclamped
Experiments: Saline ( 0, N=5), Endotoxin
w/hyperglycemia (X, tl=6), Endotoxin w/no
hyperglycemia (1:1, N=10).
o P<0.05 compared
to control;
P<O. 05 com-oared to control
and endotoxin w/hyperglycemia; 0P<0.05
compared to control, P<0.1 compared
endotoxin w/hyperglycemia.
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£igure 7.

Blood pressure fell to a similar extent in both

groups of endotoxic dogs.

As would be expected from the

similar blood pressure but lower cardiac output seen in
dogs which did not show an initial hyperglycemia, total
peripheral resistance became progressively more elevated
in this group than in either control dogs or endotoxic dogs
exhibiting the hyperglycemic phase.

These differences were

particularly striking late during the course of endotoxin
shock.

A remarkably similar pattern was seen in the pul-

monary circulation as shown in figures 8 and 9.
Glucose Clamning Experiments
A total of 25 dogs were included in these experiments: 5 hypoglycemic-clamped saline-injected dogs, 6 hypoglycemic-clamped endotoxin-injected dogs, 3 normoglycemicclamped saline-injected dogs, 4-normoglycemic-clamped endotoxin-injected dogs, 3 hyperglycemic-clamped saline-injected
dogs, and 4 hyperglycemic-clamped endotoxin-injected animals.

In all of the figures the hypoglycemic clamp data is

on the bottom, normoglycemic clamp in the middle, and hyperglycemic clamp data on the top.
from endotoxin-injected dogs.

Dark bars represent data
?reinjection data includes

all dogs in a particular clamp group. (11 hypoglycemicclamped dogs, 7 normoglycemic-clamped dogs, and 7 hyperglycemic-clamped dogs.)
In the hypoglycemic clamp experiments the average
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Fig. 7.

Total Peripheral Resistance -- Unclamped
Exneriments: Saline ( 0 , N=5), Endotoxin
w/hyperglycemia (X, N=5), Endotoxin w/no
hyperglycemia (d, N=10).
P<0.05 compared
to control;
P<0.05 comnared to control
and endotoxin w/hyperglyc~mia;
0 P<0.05
comnared to control, ?<0.1 comnared
endotoxin w/hyperglycemia.
·

*

*

------------

1000o-

- aooo--

N

E

'

II)

•

I

.
60001.
0

~

"0

~4000-

~

I -- I

c

10

20

30

40

50

60

70

80

% OF TIME TO TERMINAnON

90 100

85

Fig. 8.

Mean Pulmonary Artery Pressure -- Unclamped
Experiments: Saline ( 0, N=5), Endotoxin
w/hyperglycemia (X, N=4), Endotoxin w/no
hyperglycemia (~, N=8).
P<0.05 compared
to control;
P<0.05 compared to control
and endotoxin w/hyperglycemia;
0 P<O. 05
compared to control, ?<0.1 compared endotoxin
w/hyperglycemia.
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Fig.

9

Pulmonary Resistance -- Unclamped Experiments
Saline ( 0, N=5), Endotoxin w/hyperglycemia
(X, N=4), Endotoxin w/no hyperglycemia
(A, N=8),
P<0.05 compared to control:
P<0.05 compared to control and endotoxin
w/hyperglycemia;
0 P<0.05 compared to
control, P<0.1 compared endotoxin
w/hyperglycemia.
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time of survival for endotoxic dogs was 140z4 min following
endotoxin administration.

There were also 2 deaths in the

hypoglycemic-clamped saline-injected group at 195 and 254
min•

All normoglycemic-clamped saline-injected animals were

alive at 480 min post-injection while the mean survival time
in endotoxic normoglycemic-clamped dogs was 323z32 min.

All

hyperglycemic-clamped saline-injected dogs were also alive
at the termination of the experiment (600 min) while there
was one death in the endotoxic hyperglycemic-clamped group
prior to 600 min (249 min post endotoxin).

Thus, while

hypoglycemia significantly shortened survival (P<0.0001)
when compared to unclamped endotoxic animals (318!41 min),
hyperglycemia markedly prolonged survival (P=0.01) and
normoglycemia did not affect survival time (P=0.48).
Figure 10 shows the glucose levels in the three types
of clamps (see also fig. 24, Appendix A).

There were no

significant differences in the glucose levels during the
preclamp control period.

All three groups were different

during the preinjection clamp period (P<<0.001).

There-

spective saline- and endotoxin-injected groups for each of
the three clamps were maintained at similar levels during
the postinjection clamp period

(P~0.2)

and the three clamp

levels were all significantly different from each other
(P<<0.001).

Following the clamp the normoglycemic-clamped

endotoxin-injected dogs dropped to blood glucose levels
similar to the

hypogly~emic-clamped

dogs while three out

90

Fig. 10.

Glucose -- Glucose Clamping Experiments:
Control and ?reinjection Clamp -Hyperglycemia (~=7), Normoglycemic (N=7),
Hypoglycemic (N=11). Postinjection -light bars=saline and dark bars=endotoxin.
Hyperglycemic saline (N=J), Hyperglycemic
endotoxin (N=4), Normoglycemic saline
(N=J), Normoglycemic endotoxin (N=4),
Hypoglycemic saline (N=5), Hypoglycemic
endotoxin (N=6). Refer to text for
comparison of groups.
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of the four hyperglycemic-clamped endotoxic dogs also became
hypoglycemic (one dog remaining normoglycemic).

These

trends continued to the end of the experiments.

Normogly-

eemic-clamped saline-injected dogs fell to glucose levels
slightly below control levels and then returned to control
levels prior to the termination of the experiment.

Hyper-

glycemic-clamped saline-injected dogs fell back to control
levels or slightly higher and remained there until the end
of the experiment.
Problems with the insulin assay prevent the reporting
of reliable insulin data for the glucose clamping groups.
Fasting control levels ranged from 5 to 1410 uU/ml (mean
zSD: 253.84±306.97 for 106 samples).

This contrasts with

control samples obtained during the unclamped experiments
which averaged 27.27±21.97 for 261 control samples.

A dog

serum reference sample measured concurrently with the samples from the glucose clamping experiments ranged from 215
to 427 in 10 different assays giving a coefficient of variation of 24.6% in contrast to the Pharmacia interassay variation of 5-10% in human control sera as reported in their
brochure.

Assay-to-assay coefficients of variation ranging

from 11.8% to 70% were also obtained on fasting control
sampl~s

from the glucose clamping experiments when several

repeat measurements were made.

In two out of the three

hyperglycemic clamp control dogs measured insulin levels
remained elevated even 8 hr following cessation of glucose
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infusion (100-600 uU/ml).

Furthermore, despite the main-

tenance of normal glucose levels.in normoglycemic-clamped
saline-injected animals up to 6 hr after glucose and insulin infusions were stopped, levels were measured in the
1ooo's of uU/ml. Dilution of the dog reference serum sample in the manner of a standard curve resulted in a reasonable standard curve; therefore, it seems likely that the
interfering factor is specific for insulin antibodies.
The source of this interference is not completely known.
Glucose and insulin infusion rates for these experiments are shown in Table IV.

There were no differences in

glucose infusion rates between corresponding saline and endotoxin groups but the glucose infusion rates increased
significantly with the clamp level.

This lack of statis-

tically significant differences between saline and endotoxic dogs, however, is somewhat misleading since only
one out of five saline-injected dogs in this clamp group
required any glucose to maintain the clamp level.

In

contrast all six of the endotoxic dogs in this group required varying amounts of glucose.

While these infusion

rates have not been corrected for errors from the "desired"
level, lacking information as to the glucose space in the
endotoxic dog such correction was not possible.

In prac-

tice it became necessary to vary the insulin infusion in
the normoglycemic clamp as well as the glucose infusion.
The insulin infusion rates were significantly higher in the

Table IV Infusion Rates -- Glucose Clamping Experiments
Glucose
(mg/Kg/min)

Insulin
(U/Kg/min)

Hyperglycemic Clamp
(3)

1

6.72±1.38 2

Endotoxin (4)

1

8.68±0.98 2

Saline

Normoglycemic Clamp
(3)

1

4.72±1.30 3

0.27±0.07

Endotoxin (4)

1

4.11±0.53 3

0.66±0.09 5

(5)

1

0.23±0.23'*

4.51±0.43

Endotoxin (6)

1

0.99±0.33'*

3.49 0.88

Saline

Hypoglycemic Clamp
Saline

1:

( N)

2, 3, 4:

significant differences between clamps, P<0.05; no significant
differences between endotoxin and corresponding saline group

5:

significantly different from corresponding saline group, P<0.05
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toxic normoglycemic·clamped dogs than in the corre·
endo
sponding controls. There werep however, no differences in
the insulin infusion rates between the two groups of hypoglycemic-clamped dogs.
The arterial blood gas and pH data and the plasma
lactate levels in the clamp groups are presented in Tables

v through VIII.

There was some tendency for the hypogly-

cemic-clamped groups to become hypoxic, although this was
not significant.

These groups also became significantly

hypercapnic during the course of the experiment.

No other

consistent differences in arterial P02 and PC02 were found.
All three endotoxic groups as well as hypoglycemic-clamped
saline·injected dogs became acidotic ·- hypoglycemic clamped
endotoxin dogs to the greatest degree and the other three
groups to about the same level.

The plasma lactate levels

are consistent with these results suggesting that the acidosis in all four groups was at least in part due to the
lactacidemia.
Cardiac output is plotted in figure 11.

There were

no differences during the control or preinjection clamp
periods.

Following the injection of endotoxin all endo-

toxic dogs fell to similar levels while all three salineinjected groups remained at control levels.

Following the

clamp there was a further deterioration in the cardiac
output in hypoglycemic-clamped endotoxin-injected dogs
while all other groups essentially remained at the same

'!'able V Arterial pH

--

Glucose Clamping Experiments

.E.!!

...

Control 1

Preinj 1
Clamp

Postinj
Clamp

Post Clamp

Hyperglycemic Clamp
( 3 )2
Saline
Endotoxin (4)2

7.39±0.01

7.41±0.02

7.40±0.02
7.22±0.03 3

7.36±0.02
7.23±0.06 3

Normoglycemic Clamp
( 3 )2
Saline
Endotoxin (4):i:

7.36±0.0J

7.37±0.03

7.35±0.07
7.19±0.05 3

7.37±0.06
7.16±0.04 3

Hypoglycemic Clamp
( 5 )2
Saline
Endotoxin (6)2

7.34±0.02

7.31±0.03

7.19±0.05 3
?.09±0.03 ..

7.16±0.04 3
6.99±0.04 ..

1:

for control and preinjection clamp-- Hyperglycemic clamp. N=?;
Norrnoglycemic clamp, N=?; Hypoglycemic clamp, N=11

2:

(N)

3:

significantly different from hyperglycemic and normoglycemic clamp salirie, P<0.05

4:

significantly different from all other groups, P<0.05

,

,. Table

VI Arterial P0 2

--

Glucose Clamping Experiments

P02 {mmllg}
Control 1

Preinj 1
Clamp

Postinj
Clamp

Hyperglycemic Clamp
Saline
(3) 2
Endotoxin (4) 2

85±3

95±4

95±5 3
?3±4

85±4
?3±8

Normoglycernic Clamp
Saline
(3) 2
Endotoxin ( 1~) 2

?8±4

92±6

83±1 0
82±4

?8±9
??±4

Hypoglycemic Clamp
Saline
(5) 2
Endotoxin (6) 2

93±2

96±4

?4±4
?1 ±4

66±5
5?±?

Normoglycemic Clamp, N=?;

Post Clamp

1:

lfyperglycemic Clamp, N=?;

Hypoglycemic Clamp, N=11

2:

( N)

3:

not significantly different from Normoglycemic saline (P=O.O?), significantly
different from all other groups (P<0.05); no other significant differences

Table VII Arterial PC0 2

--

Glucose Clamping Experiments
PC0 2 (mmHg)

Control 1

Preinj 1
Clamp

Postinj
Clamp

30±2

34±3

29±7

Post Clamp

Hyperglycemic Clamp
(3)

2

Endotoxin (4)

2

Saline

35 ±1

Normoglycemic Clamp
(3)

2

Endotoxin (4)

2

Saline

33±3

28±2

33±4
29±2

26±2

48±6 3
43±4 ..

57±4 3

33±4

Hypoglycemic Clamp
Saline

(5) 2

Endotoxin

(6) 2

35±4

32±3

Normoglycemic Clamp, N=7;

61 ±5 3

Hypoglycemic Clamp, N=11

1:
2:

llyperglycemic Clamp, N=7;
( N)

3:

significantly different from all other groups, P<0.05

4:

significantly different from Hyperglycemic saline and Normoglycemic
endotoxin, P<0.02

5:

significantly different from Normoglycemic saline, P=0.05
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Table VIII Plasma Lactate
Lactate (mmol/1)
Unclamped

( 14) l
Control
Early Shock ( 9) l
( 9) l
Late Shock

Glucose Clamping
Postinj
Post Clamp
Clamn

0.93±0.09
3.20±0.50 2
4.20±0.70 2

Hyperglycemic Clamp
( 3) l
Saline
( 4) l
Endotoxin

1.30±0.20
1.50:t0.20 3

0.70±0.20
2.20:t0.10 3

Normoglycemic Clamp
(3)1
Saline
( 4) l
Endotoxin

1.20:t0.10
2.00±0.20 3

1.40±0.10 5
2.50:t0.20 3

Hypoglycemic Clamp
( 5) l
Saline
(6)1
Endotoxin

1.30:t0.20
2.90±0.201+

1.70±0.30 6
3.50±0.301+

1:

(N)

2:

early shock = 0-50% of postinjection time course; late
shock = 50-100%; significantly different from control
by unpaired t test, P<0.001
significantly different frpm saline-injected clamp
groups and from control, P.<O. 05
significantly different from all other groups, P<0.05
significantly different from all groups except Hypoglycemic saline, P<0.05
significantly different from all other groups except
Hyperglycemic endotoxin, P<0.05

3:
4:
5:
6:

Fig. 11.

Cardiac Output -- Glucose Clamping
Experiments: Control and ?reinjection
Clam~ -- Hyperglycemic (N=7), Normoglycemic
(N=7), Hypoglycemic (N=11). Postinjection
light bars=saline and dark bars=
endotoxin. Hyperglycemic saline (N=J),
Hyperglycemic endotoxin (N=4),
Normoglycemic saline (N=J), Normoglycemic
endotoxin (N=4), Hypoglycemic saline (N=5),
Hypoglycemic endotoxin (N=6). Refer to
text for comparison of groups. *All
animals in these two groups were dead at
the end of the experiment.
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levels as during the clamp.

Subsequently all of the hypo-

glycemic- and normoglycemic-clamped endotoxin-injected
dogs died while the hypoglycemic-clamped saline-injected
and the hyperglycemic-clamped endotoxin-injected dogs fell
to similar levels.

The normoglycemic-clamped and hypergly-

cemic-clamped saline-injected animals remained at control
levels throughout the experiment.
Left ventricular peak systolic pressure (figure 12)
and left ventricular end-diastolic pressure (figure 13)
are shown in the next two figures.

During the preinjection

clamp period the hypoglycemic-clamped dogs began to fall to
lower peak systolic pressures.

With the injection of endo-

toxin left ventricular predsure fell to the same extent in
all three endotoxin-injected groups.

During the clamp the

left ventricular peak systolic pressure continued to fall
in the hypoglycemic-clamped saline-injected dogs but not to
the same extent as any of the endotoxic groups.

Following

the clamp period left ventricular pressure continued to
fall in the hypoglycemic-clamped endotoxic group but remained about the same in the other two endotoxic groups.
The hypoglycemic-clamped saline group continued to decline
but was still higher than any of the three endotoxic groups.
Prior to the termination of the experiment left ventricular
pressure was similar in the hypoglycemic-clamped salineinjected dogs and the hyperglycemic-clamned dogs while
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Fig. 12.

Left ventricular Peak Systolic Pressure -Glucose Clamping Experiments: Control and
Preinjection Clamp -- Hyperglycemic (N=7),
Normoglycemic (N=7), Hypoglycemic (N=11 ),
Postinjection -- light bar~=saline and
dark bars=endotoxin. Hyperglycemic saline
(N=3), Hyperglycemic endotoxin (N=4),
Normoglycemic saline (N=3), Normoglycemic
endotoxin (N=4), Hypoglycemic saline (N=5),
Hypoglycemic endotoxin (N=6). Refer to
text for comparisons of groups. *All
animals in these two groups were dead at
the end of the experiment.
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Fig. 13.

Left Ventricular End-diastolic Pressure -Glucose Clamping Experiments: Control and
Preinjection Clamp-- Hyperglycemic (N:7),
Normoglycemic (N:7), Hypoglycemic (N:11).
Postinjection -- light bars:saline and dark
bars:endotoxin. Hyperglycemic saline (N=J),
Hyperglycemic endotoxin (N:4), Normoglycemic
saline (N=3), Normoglycemic endotoxin (N=4),
Hypoglycemic saline (N:5), Hypoglycemic
endotoxin (N=6). Refer to the text for
comparisons of groups. *All animals in
these two groups were dead at the end of the
experiment.
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the remaining endotoxic dogs all died.

Left ventricular

pressure remained fairly steady throughout the experiment
in the normoglycemic- and hyperglycemic-clamped
injected control dogs.

saline~

There were no differences in left

ventricular end-diastolic pressures until just prior to
the termination of the experiment in any of the groups.
This is probably due to the quantity of fluid infused during the glucose clamps since end-diastolic pressure fell
in unclamped dogs.
A similar pattern of events was also seen for stroke
work. shown in figure 14, with the exception that hypoglycemic~clamped

saline-injected dogs did not fall to the same

extent as hyperglycemic-clamped endotoxic dogs.

Otherwise,

cardiac work deteriorated most rapidly in hypoglycemicclamped endotoxin dogs, followed by

nor~oglycemic-clamped

and then hyperglycemic-clamped endotoxic dogs.

Normogly-

cemic- and hyperglycemic-clamped saline-injected dogs remained at control levels throughout the experiment.
Figures 15 and 16 show the mean systolic blood
pressure and the total peripheral resistance respectively.
Systemic arterial pressure followed a similar pattern in
all groups as for the cardiac performance parameters.
While qualitatively the systemic resistance seems to follow the same pattern in hypoglycemic-clamped endotoxic
dogs as for unclamped dogs not exhibiting a hyperglycemic
=hase, there were no significant differences among any
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Fig. 14.

Left Ventricular Stroke Work -- Glucose
Clamping Experiments: Control and
Preinjection Clamp -- Hyperglycemic (J=7),
Normoglycemic (N=7), Hypoglycemic (N=11).
Postinjection -- light bars=saline and dark
bars=endotoxin. Hyperglycemic saline (N=J),
Hyperglycemic endotoxin (N=4), Normoglycemic
saline (N=J), Normoglycemic endotoxin (N=4),
Hypoglycemic saline (N=5), Hypoglycemic
endotoxin (N=6). Refer to the text for
comparisons of groups. *All animals in
these two groups were dead at the end of
the experiment.
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Fig. 15.

Mean Systemic Arterial Pressure -- Glucose
Clamping Experiments: Control and
Preinjection Clamp-- Hyperglycemic (N=7),
Normoglycemic (N=7), Hypoglycemic (N=11),
Postinjection -- light bars=saline and
dark bars=endotoxin. Hyperglycemic saline
(N=J), Hyperglycemic endotoxin (N=4),
Normoglycemic saline (N=J), Normoglycemic
endotoxin (N=4), Hypoglycemic saline (N=5),
Hypoglycemic endotoxin (N=6). Refer to
text for comparisons of groups. *All animals
in these two groups were dead at the end of
the experiment.
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Fig. 16.

Total Peripheral Resistance -- Glucose
Clamping Experiments: Con~rol and
?reinjection Clamp -- Hyperglycemic (~~7),
Normoglycemic (N=7), Hypoglycemic (N=11).
Postinjection -- light bars=saline and
dark bars=endotoxin. Hyperglycemic saline
(N=3), Hyperglycemic endotoxin (H=4),
Normoglycemic saline (N=3), Normoglycemic
endotoxin (N=4), Hypoglycemic saline (N=5),
Hypoglycemic endotoxin (N=6). Refer to
text for comparisons of groups.
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of the groups at any of the time points.

This is probably

due to the high variability of the calculated resistance
in general and the highly variable response of the other
two endotoxic groups.
Figures 17 and 18 show the mean pulmonary artery
pressures and the pulmonary resistance.

There were no sig-

nificant differences in mean pulmonary resistance.

There

were no significant differences in mean pulmonary artery
pressure in any of the groups through the glucose clamping
period.

Following the clamp, however, pressure started to

fall in all three endotoxic groups and the hypoglycemicclamped saline-injected group.

The pattern was similar at

the termination of the experiment to that seen for all of
the other cardiovascular parameters.

Pulmonary artery re-

sistance was significantly higher than any o£' the other
groups during the postclamp period in hypoglycemic-clamped
endotoxic dogs.

Thus, pulmonary resistance in these animals

followed a pattern reminiscent of the unclamped endotoxic
dogs showing early hyperglycemia.
Summary of Results
To summarize the results:

Two patterns of glucose

changes were seen in unclamped endotoxic dogs.

One group

of dogs showed initial hyperglycemia while the other did
not.

Bo t.n·
.v. . atterns we1'"
~
_e

·

+
assoc~ave
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· t'a .yperinsulinemia.
h
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Fig. 17.

Mean Pulmonary Artery Pressure -- Glucose
Clamping Experiments: Control and
?reinjection Clamp -- Hyperglycemic (N=7),
Normoglycemic (N=7), Hypoglycemic (N=11).
Postinjection -- light bars=saline and dark
bars=endotoxin. Hyperglycemic saline (N=3),
Hyperglycemic endotoxin (N=4), Normoglycemic
saline (N=3), Normoglycemic endotoxin (N=4),
Hypoglycemic saline (N=5), Hypoglycemic
endotoxin (N=6). Refer to text for
comparisons of groups. *All animals in
these two groups were dead at the end of
the experiment.
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Fig. 18.

Pulmonary Resistance -- Glucose Clamping
Experiments: Control and Preinjection
Clamp -- Hyperglycemic (N=7), Normoglycemic
(N=7), Hypoglycemic (N=11). Postinjection
-- light bars=saline and dark bars=endotoxin.
Hyperglycemic saline (~=3), Hyperglycemic
endotoxin (N=4), Normoglycemic saline (N=3),
Normoglycemic endotoxin (N=4), ~ypoglycemic
saline (N=5), Hypoglycemic endotoxin (N=6).
Refer to the text for comparisons of groups.
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Cardiac output and stroke work tended to be better in dogs
exhibiting early hyperglycemia.

While left ventricular

pressure was similar in both groups of endotoxic dogs, -animals showing the initial hyperglycemic phase had lower
end~diastolic

pressures.

Mean systemic and pulmonary ar-

terial pressures were also similar.

This is due to higher

resistance in both systemic and pulmonary circulations in
dogs not experiencing the initial hyperglycemia.

There were

no consistent changes in arterial blood gases in either
group of endotoxic dogs.

Both groups of endotoxic dogs also

developed lactacidemia leading to metabolic acidosis to
about the same degree.
In glucose clamping experiments all endotoxic dogs
had similar cardiovascular performance during the clamp.
However, after terminating the clamp hypoglycemic-clamped
endotoxic dogs rapidly deteriorated and succumbed to shock
while hyperglycemic-clamped dogs were protected and normoglycemic clamped dogs followed a normal time course.

The

cardiovascular patterns reflect these differences in the
ability to survive and hypoglycemic-clamped endotoxic dogs
followed a pattern reminiscent of unclamped dogs which did
not go through an early hyperglycemic phase.

Cardiovascular

performance was compromised in hypoglycemic-clamped dogs
given saline to about the same extent as in hyperglycemicclamped endotoxic dogs.

All endotoxic dogs became acidotic
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and lactacidemic -- hypoglycemic-clamped endotoxic dogs to
the greatest extent.

Hypoglycemic clamped dogs given saline

also became acidotic.

Both groups of hypoglycemic-clamped

dogs also tended to become hypoxic and hypercapnic.

CHAPTER VI

DISCUSSION
Metabolic Effects of Endotoxin
in the Canine-Model

--

These results, using continuous glucose monitoring,
conclusively demonstrate two patterns of glucose changes in
endotoxic dogs: some dogs exhibit

an initial hyperglycemic

phase before becoming hypoglycemic, while other dogs proceed directly into the hypoglycemic phase.

This confirms

the earlier work of Berk et al. (9) and Hinshaw and colleagues (100) using discontinuous sampling of blood glucose.
The mechanism behind these two patterns is unclear but may
involve differences in glycogen reserves following an overnight fast, differences in nutritional status, or differences in the hormonal milieu.

Further study is needed to

determine the exact mechanism.
Hyperinsulinemia was also found to occur in the endotoxic dog analogous to the hyperinsulinemia which has already been demonstrated in the endotoxic rat by Filkins and
colleagues (23, 220).

At no time period did insulin fall

below control in either group of endotoxic dogs.

This re-

sult is in contradiction to several reports in the literature on endotoxin shock in the dog which either show depressed levels throughout or only early elevations in
1 21
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association with a hyperglycemic phase (142, 199).
are several explanations for this discrepancy.

There

First, in

previous studies measurements were made at only a few time
points.

Since considerable fluctuation was seen in the pre-

sent experiments in which measurements were made every 15
minutes (see Appendix A), it is possible that similar elevations of insulin levels were simply missed in earlier studies.

Differences in the insulin response based on differ-

ences in lethality or endotoxin dose are also possible.
Finally, the results of the present experiments cannot be
taken as conclusive evidence of hyperinsulinemia in the dog
since during glucose clamping experiments the possible presence of factors in dog serum which lead to spuriously high
measurements in the radioimmunoassay for insulin was discovered.

The nature of this interference is unknown.

Since

dilution of dog reference serum samples gave a reasonable
standard curve, i t is likely that the interfering factor is
specific for insulin antibodies rather than interfering
through non-specific binding.

This is not an isolated

.nroblem since others have encountered the same .nroblem of
spuriously high insulin levels in dog serum (personal communication with N. Manson) and is

~orthy

of further study

since i t may be the basis for the widely varying results
obtained in studies of insulin levels in the endotoxic dog
(14, 142, 199).

The question of the role of pancreatic in-

sulin in the develonment of hypoglycemia in the endotoxic
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dog, thus, remains unanswered.
During glucose clamping no effect of endotoxin on
glucose infusion rates was observed. This result is contrary
to numerous other observations that glucose utilization is
increased in endotoxic animals (5, 53, 56, 57, 88, 152, 173,
218).

There are several explanations for this discrepancy.

First, endogenous sources of glucose may be present which
add to the glucose supplied exogenously by the infusion.
Thus, the total glucose utilized was not accounted for by
the infusion.

Second, lacking specific information as to

the glucose space in the endotoxic dog it is impossible to
correct the glucose infusion rates to the actual glucose
utilized.

Since the glucose space may change following the

administration of endotoxin and since different infusion
rates might be due to wider variations of the actual glucose
level from the desired level rather than differences in utilization, these corrections might be very important in the
endotoxic dog model.

Furthermore, since it became necessary

to vary the insulin infusion rate as well as the glucose
infusion rate to lower the glucose level in the normoglycemic-clamped dogs and lacking insulin data for the glucose
clamping experiments, it is difficult to interpret the results in terms of tissue insulin sensitivity.

In addition,

in some animals it was necessary to give additional bolus
injections of insulin or glucose in all three of the

cla~ps

in order to maintain the glucose level -- thus, adding
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another complexity to the analysis and interpretation.
While normoglycemic·clamped endotoxin dogs had higher insulin infusion rates but similar glucose infusion rates when
compared to normoglycemic·clamped saline-injected dogs.
possibly indicating insulin resistance, this conclusion is
not supported by the results of the other two glucose
clamps.

There was a much greater increase in glucose util-

ization with hyperglycemia in endotoxin dogs thap in salineinjected dogs (112% versus 43%).

Furthermore, while there

were no statistically significant differences in glucose
infusion rates in hypoglycemic·clamped dogs, the statistics
in this case are undoubtedly

~isleading

since only one out

of five dogs in this group given saline required any glucose
to maintain the clamp level.
hypoglycemic-cla~ped

cose.

In contrast, all six endotoxic,

dogs required varying amounts of glu-

Both of these results suggest insulin hypersensi-

tivity in the endotoxic dog.

Further refinements of the

glucose clamping technique are clearly needed before these
techniques can be used in the metabolic analysis of the
endotoxic dog.

In particular, it is necessary to antici-

pate the changes in blood glucose levels to a greater extent in order to minimize the deviations from the desired
level as DeFronzo and his colleagues have done (38).

While

the manual control technique used in this study was useful
in attaining the initial goal of developing a glucose
clamping model in the endotoxic dog, there are certain
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drawbacks to this technique.

Pacini, Finegood, and Berg-

man (164) have recently pointed out that such human interaction entails a degree of bias and is also tedious. Because of these problems it is desirable to develop automatic means of feedback control of blood glucose for glucose clamping experiments.

Thus, better results might be

obtained if a more mathematical basis for the infusion was
used rather than the trial-and-error method used in the
present experiments.

If the trial-and-error method, however,

did not provide satisfactory control of glucose levels, even
on a crude level, sophisticated mathematical modelling probably would not have helped.

Fairly good control was ob-

tained using the trial-and-error method (see Appendix A);
this can, however, be improved upon with further refinements
of the glucose clamping technique.

These experiments thus

provide a good foundation for the development of glucose
clamping techniques in the endotoxic dog model.
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Associated with the two patterns of glucose changes
in the unclamped experiments were differences in the pattern
of circulatory failure.

Dogs which did not show the early
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hYP e

r~lycemia
o

had poorer cardiac output and stroke work

than dogs which did go through an early hyperglycemic phase.
The finding of similar left ventricular pressures in the
group which did not show hyperglycemia but at higher enddiastolic pressures is also consistent with the poorer
cardiac function in this group.

Since venous return and

effective blood volume also fall during endotoxin shock
(J1, 101), endotoxic cardiac failure is complicated by
changes in preload.

This may explain the fall in end-

diastolic pressure in both groups of endotoxic dogs.

How-

ever, the lack of any differences in peak systolic pressure
•• especially in light of a tendency toward greater afterload as assessed by total peripheral resistance in dogs
with no hyperglycemic phase -- is harder to explain.

Part-

ly this may be the problem of finding statistically significant differences between experimental groups using an
analysis of variance when there are relatively large differences between the control group and the experimental
groups but only small differences between the experimental
groups.

Thus, the variance between the control groups

and the experimental groups is large but between the experimental groups the variance is small and larger differences
are needed to find a statistical significance.

The high de-

gree of lethality (100%) in both groups of endotoxic dogs
also would tend to blur any real distinction in the cardiovascular performance of the two groups.

In spite of
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the poorer cardiac performance in dogs not showing early
hyperglycemia, these dogs were able to maintain similar
mean systemic arterial pressures at the tremendous expense
of progressive increases in peripheral resistance leading
to further tissue ischemia.

Further experiments using a

less potent model of endotoxin shock are needed to sort out
the effects of the pattern of glucose dyshomeostasis on cardiovascular function and the importance of the ability of
the animal to maintain blood glucose to survival and the
maintenance of normal circulatory function.
Evidence from Glucose Clamuing Studies
Hypoglycemia markedly curtailed survival while hyperglycemia even for only the initial two hours after endotoxin
injection markedly prolonged survival.

In contrast, mainte-

nance of normoglycemia over the first two hours of endotoxicosis left the time course of endotoxin shock unaltered.
Cardiovascular status paralleled these alterations in survival.

In addition, hypoglycemia tended to depress cardio-

vascular function even without concomitant endotoxemia.
These effects of glucose clamping could be attributed to mechanisms other than control of blood glucose
concentrations.

First fluids given during the clamp may

have provided some support to the cardiovascular system
during shock.

Volume overload, on the other hand, may be

detrimental to an animal already in cardiac failure.

The
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lack of any differences in left ventricular end-diastolic
pressure between any of the groups except preterminally
makes it unlikely, however, that this is a factor.

Se~ond,

insulin probably has its own effects on cardiovascular
runction (82, 117, 125, 161, 208, 211).

Both Hiatt and

coworkers (125, 161) and Downing and associates (82, 208)
have shown that while insulin has a positive inotropic
effect of its own, insulin also blocks the positive chronotropic and inotropic actions of catecholamines.

Thus in-

sulin or an insulin-like activity may in addition to causing the hypoglycemia of endotoxin shock, block the supportive effects of epinephrine and norepinephrine on the
the heart.

Furthermore, insulin and possibly insulin-like

agents are known to have a number of effects on ionic
fluxes -- especially potassium flux (117).

Alterations in

ion fluxes -- especially in the face of hypoglycemia -may further disturb cardiac electrophysiology.

It is

possible that hyperinsulinism -- whether due to increased
secretion of insulin by the pancreas or to insulin-like
activities -- may further impair cardiac performance.
Since most reports, however, ascribe positive inotropic and
beneficial effects of insulin infusions under a variety of
conditions (117, 211), it seems likely that the elevated
insulin levels -- either because of an insulin infusion or
in response to a glucose load -- in all three endotoxic
clamp groups are beneficial and explain the similar levels
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of cardiovascular variables during the clamp.

It seems

likely that insulin as well as the volume of infusions is
supporting the cardiovascular system of endotoxic animals
during these clamps.

Following the cessation of all in-

fusions the prevailing glucose level becomes the overriding factor in maintaining circulatory function and
tissue perfusion.

It is possible that the hyperinsulinemia

which occurs following endotoxin administration might be a
compensatory mechanism which together with hyperglycemia
provides an endogenous glucose and insulin solution with
the same beneficial effects as exogenously administered
glucose-insulin-potassium solutions (117, 211).

This mech-

anism -- in a similar manner to increases in peripheral
resistance which help to maintain blood pressure at the
expense of tissues which become ischemic -- becomes counterproductive and leads to the development of hypoglycemia
when the hyperglycemia can no longer be maintained.

The

possibility that insulin blocks sympathetic support of the
myocardium and, therefore, has detrimental effects, as
postulated by Hiatt (82, 208) and Downing (125, 161) cannot, however, be eliminated.

It seems likely, though,

that the prevailing glucose levels are the controlling factor.

Thus, one can alter the cardiovascular response to the

administration of endotoxin and the ability of the dog to
survive simply by altering the glycemic status.

Dogs which

are rendered hyperglycemic receive sufficient glucose to
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more than keep up with metabolism even after the glucose
infusion is stopped so that the needs of the cardiovascular
system during the endotoxic stress continue to be supplied.
Normoglycemic clamping, on the other hand, provides only
sufficient glucose to supply the current needs and the hypoglycemic clamp removes the preexisting glucose reserve with
detrimental consequences for cardiovascular functions.
Hypoglycemia, therefore, plays a detrimental role during the
course of shock while hyperglycemia appears to be a compensatory mechanism to maintain metabolic homeostasis and to
prevent the ensuing cardiovascular failure.
Glucose

Monitoring~

~ ~

Treatment

2£

Glucose Clamping
Endotoxin Shock

These experiments point to the need for metabolic
as well as circulatory monitoring in septic patients as has
been proposed by Siegel (192) and Duff (42).

The results

of the glucose clamping studies also indicate that glucose
clamping may be an effective treatment for shock by helping
to prevent the circulatory sequelae of sepsis.

It is

unknown whether there is a point where the effects of hypoglycemia become irreversible -- in analogy to the Wiggers'
concept of irreversibility following hemmorhage (214).

If

glucose clamping is to be used as a treatment it is necessary to determine the best treatment regimen -- whether glucose alone or in conjunction with insulin is most effective.
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clearly it is important to have adequate assessment of
metabolic status in order to appropriately administer treatment.

In these experiments normoglycemic clamping was just

as effective a treatment as hyperglycemic clamping early
during the course of shock as assessed by the improvement in
cardiovascular status, but only the hyperglycemic clamp was
able to prolong survival following cessation of treatment.
Furthermore, cardiovascular status deteriorated even in
hyperglycemic-clamped endotoxic dogs.

An assessment must

be made as to when glucose clamping should be instituted and
when it is safe to end that treatment.
the

rela~ionship

Further studies of

of cardiovascular status to glucose homeo-

stasis and the usefulness of glucose clamping as a treatment
for endotcxic or septic shock are clearly needed.
Mechanism for the Role of
Hynoglycemia iu CardiovasCUTar~ailure
Reticuloendothelial System Involvement
Buchanan and Filkins (22) demonstrated that hypoglycemia depresses phagocytosis of both colloidal carbon and
endotoxin using an in vivo model of insulin-induced hypoglycemia and in vivo tests of phagocytic clearance.

Thus, the

hypoglycemia of endotoxin shock may contribute to the RES
depression which occurs during endotoxin as well as other
forms of circulatory shock (39, 59, 188).

Since the RES is

responsible for clearing cardia- and vasotoxic substances
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as well as endotoxin from the blood, depression of this
vital function may lead to cardiac and peripheral vascular
failure following endotoxin administration by allowing·such
toxic substances to accumulate.

In addition, there is ev-

idence that RES depression alone can lead to a state of
circulatory shock (7, 212, 213).

Recently the results of

Buchanan and Filkins have been confirmed using a slightly
different model (116).

There are, however, some striking

differences between the quantitative results of this latter
study and those of Buchanan and Filkins.

These differences

suggest that duration. a.7J.d the rate of induction of hypoglycemia may be important factors in the development of RES
dysfunction as well as the plasma glucose level.

Using an

in situ perfused liver model, Kober and Filkins (116) also

demonstrated that the hypoglycemic depression of RES phagocytosis is probably due to a direct metabolic effect of
glucose deprivation on the Kupffer cells of the liver.
Other mechanisms such as humoral mediators or maldistribution of blood flow in the liver cannot be eliminated
and may operate in conjunction with a direct effect of
glucose deprivation.

A direct metabolic effect is entirely

consistent with the evidence for a glucose-based metabolism in macrophages (76, 113, 163, 178, 187).

It is

also of interest to note that the RES may play a role in the
development of hypoglycemia through its exocytic functions
(58).

Thus, both the endocytic and exocytic functions
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of the RES may play an extremely important role in the pathogenesis of endotoxin shock by providing a positive feedback
link via hypoglycemia (58).
The effects of hypoglycemia on RES function in the
dog have not been explored.

However, since this is a po-

tential site for positive feedback in the development of
circulatory shock, it is in theory an important mechanism.
Pulmonary Hemodynamics

~

Fluid Balance

The development of pulmonary edema during hypoglycemic episodes has been described clinically (8).

The pre-

sence of a fulminating edema was also noted in conjunction
with the previously mentioned studies of RES depression
during hypoglycemia (unpublished observations).

Two paten-

tial mechanisms for the pathogenesis of this pulmonary
edema during hypoglycemia have been suggested in the literature (8).

The first is a neurogenic mechanism leading to

pulmonary vasoconstriction and increased pulmonary vascular
resistance (139).

Such increases in pulmonary vascular

resistance are also important since the high afterload to
right ventricular ejection can potentially lead to right
ventricular failure.

The second mechanism is an effect of

hypoglycemia to increase alveolocapillary permeability -either directly or indirectly through humoral mediators
-- leading to increased fluid flux out of the pulmonary
vasculature (71 ).

Thus, through effects on pulmonary
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vascular resistance and pulmonary capillary fluid balance.
hypoglycemia can potentially contritute to the myocardial
failure, hypovolemia, and the systemic hypoxia of endotoxin
shock.
Lung fluid balance was not studied in the present set
of experiments.

However, both hypoglycemic-clamped endo-

toxic dogs and unclamped endotoxic dogs without early hyperglycemia show increases in pulmonary resistance after the
administration of endotoxin.

The increased pulmonary re-

sistance could have contributed to the poorer cardiovascular
picture in these groups of dogs by contributing to the development of myocardial failure or through an alteration in
lung fluid balance.

The contribution of increased pulmonary

resistance to cardiovascular failure after endotoxin injection and the mechanism of the role of hypoglycemia in producing increased pulmonary resistance, however, requires
further study.
Metabolic Reguirements £! Vascular
Smooth Muscle
Until recently it was believed that vascular smooth
muscle metabolism was largely dependent on carbohydrate as
a source of fuel.

It has now been shown that other sub-

strates can be utilized by vascular smooth muscle (29) and
that there may be differences between vascular beds (37).
This issue remains controversial.

As for other tissues,
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glucose becomes a major substrate for vascular smooth
muscle during hypoxia.

It may be that as hypoglycemia and

hypoxia develop during endotoxin shock that vasoconstriction
cannot be maintained in non-vital beds.

This would lead

to a fall in systemic arterial pressure and a release of
cardia- and vasotoxic substances from these beds.

Malik

and McGiff (141), on the other hand, have demonstrated increased responsiveness to adrenergic influences in the
splanchnic circulation following glucose deprivation.

This

could lead to increased vasoconstriction in the splanchnic
bed resulting in ischemia and production of cardia- and
vasotoxic materials from damaged splanchnic organs.

Thus,

potentially, there are two opposing effects of hypoglycemia
on the peripheral vasculature:
ability to vascular smooth

decreased substrate avail-

~uscle

and increased responsive-

ness to sympathetic nervous discharge.

The balance between

these two effects will determine the actual response to the
hypoglycemia of endotoxin shock in a given vascular bed.
In addition, this balance may change throughout the course
of shock.
In these experiments, total peripheral resistance
was maintained at control or elevated levels up until the
time of death in all groups of endotoxic dogs.

Furthermore,

peripheral resistance seemed to be a function of cardiac
output (i.e. the lower the cardiac output the higher the
peripheral resistance).

This implies that the peripheral
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~asculature

is capable of responding to the normal reflexes

to maintain blood pressure.

Thus, an overall effect of glu-

cose deprivation during endotoxin shock on the ability of
vascular smooth muscle to contract seems not to be present
in spite of the very low levels of blood glucose.

Effects

on individual beds, however, cannot be ruled out.

These

data, on the other hand, are consistent with an enhancement
of adrenergic vasoconstrictor mechanisms, since peripheral
resistance was elevated in unclamped dogs not exhibiting
early hyperglycemia and in hypoglycemic-clamped endotoxic
dogs (although this did not reach statistical significance
because of the high variability in the response of normoglycemic-clamped endotoxic dogs).

This hypothesis requires

more direct study of the vascular response to adrenergic
stimulation after endotoxin and during hypoglycemia.
Hyuoglycemia ~ Cardiac Function
during Endotoxicosis
Evidence from the unclamped experiments suggests
that the pattern of glucose dyshomeostasis affects primarily
cardiac function (cardiac output and stroke work are affected by the pattern of glucose dyshomeostasis while the
~

response of the peripheral vasculature follows reflexly to
support systemic arterial pressure even in late shock.

The

results of the glucose clamping experiments are also consistent with this hypothesis since the same pattern of
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deteriorating cardiac function with increasing systemic and
pulmonary resistance is seen in hypoglycemic-clamped endotoxic dogs.

This is also consistent with the current c_on-

cept that the heart is the major site of circulatory failure during endotoxicosis rather than the peripheral vasculature (78).

However, most of the studies of cardiac func-

tion following endotoxin injection -- including the present
study -- have measured global circulatory parameters

~uch

as systemic and pulmonary arterial pressures, cardiac output, and left ventricular pressure which are affected by
other factors as well as the contractile status of the
heart.

Further investigations utilizing more sophisticated

means to assess cardiac performance and reserve -- such as
wall thickness and regional shortening as well as methods
of probing cardiac function -- are needed to define the role
of the heart in endotoxic shock in general and more specifically the effect of the progressive hypoglycemia of endotoxin shock on cardiac function.

Several mechanisms may

lead to cardiac failure during endotoxin shock.

The role of

RES, pulmonary resistance, and lung fluid balance have already been discussed.
Some of the earliest

clue~

to the potential effects

of hypoglycemia on cardiovascular performance come from
studies during the era of insulin shock treatments.

Ern-

stene and Altschule (47) in 1931 discussed the dangers of
diminished myocardial reserve during hypoglycemic episodes.

138
In the same year Middleton and Oatway (154) also noted the
potential for myocardial injury following hypoglycemia.
Additional evidence for this potential has been provided.
more recently by Libby, Maroko, and Braunwald (134).

How-

ever, their 1975 study provided no information as to the
mechanism and merely demonstrated the increase in myocardial injury following coronary artery ligation during hypoglycemia as assessed by S-T segment changes and myocardial
creatine phosphokinase levels.

Edwards and Page (43) as

far back as 1924 emphasized the decreased functional capacity of the heart during hypoglycemic episodes and made the
statement that the changes in cardiovascular function which
they observed during hypoglycemia

11

may present the essential

features of circulatory failure shock."

In addition to

these observations, the beneficial effects of insulin and
glucose on the ischemic myocardium and also on the shock
heart are well-known and have been extensively reviewed
(117).
Bricknell and Opie (17, 18) have recently advanced
the idea, supported by the earlier work of Gercken (66) and
Gudbjarnason and coworkers (73), that the maintenance of
membrane function in the heart is dependent on glycolytically produced ATP, and, thus, on a source of glucose.
This concept is also supported by the work of Girardier (67)
and of McDonald, Hunter, and McLeod (148) showing that glucose is necessary for the maintenance of normal action
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potentials in the heart.

As might be expected from this

concept nodal tissue as well as tissue of the conducting
system seems to be more dependent on carbohydrate
olism (114, 121).

metab~

These cardiac tissues are also more

susceptible to the effects of glucose deprivation in the
race of hypoxia (190).

Hypoglycemia -- even without con-

comitant ischemia and hypoxia -- could, thus, lead to altered cardiac electrophysiology, dysrhythmias, depressed
contractility, and altered responsivity to cholinergic and
adrenergic influences resulting in autonomic imbalance via
a depression of myocardial membrane function.

Although the

hypothesis of compartmentalization of ATP is certainly not
a proven theory, it seems clear that while the major substrate of the heart under most circumstances is free fatty
acids, the approximately 30% which is glucose and other
carbohydrates (117) is just as important in maintaining
normal cardiac function.

During myocardial ischemia which

has been demonstrated during endotoxin shock (15, 94, 115),
glucose supply becomes even more critical since ATP can only
be produced from free fatty acids oxidatively (117).
colysis, on the other hand, requires no oxygen.

Gly-

Further-

more, oxidative metabolism from glucose requires less oxygen than fatty acid metabolism (117).

Thus, glucose be-

comes the preferred substrate during ischemia and hypoxia
when oxygen supply is limited.

Numerous studies have shown

that myocardial function during ischemia and hypoxia is, in
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fact, improved when glucose is supplied as the substrate as
opposed to free fatty acids (117).

In experiments in

which high levels of free fatty acids were infused in normal
dogs -- thus, turning off glucose utilization -- ischemiclike changes were produced in the electrocardiogram (105).
The importance of glucose to the maintenance of cardiac
performance is also suggested by clinical evidence that
there is a relationship between the degree of glucose intolerance following myocardial infarction (so-called stress
diabetes) and the degree of left ventricular dysfunction
(182, 216).

There is some similarity between the metabolic

problems created by such glucose intolerance and those created by the hypoglycemia of endotoxin shock.

During stress-

induced glucose intolerance the supply of glucose is intact
but transport into and utilization by the cells is impaired,
whereas during endotoxic hypoglycemia the central supply of
glucose is limited.

The net result is effectively the same:

The myocardial cells do not receive sufficient substrate to
maintain adequate ventricular performance.

It may very well

be that the supply of glucose is a critical factor in several pathophysiological states effecting myocardial performance.

Maintenance of normal glucose homeostasis may

therefore be important in the maintenance of normal cardiovascular function.

The implication is that the supply man-

agement system and the delivery system are highly integrated
functions and that neither one works well by itself.

This
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concept is certainly worthy of further study.
In this set of experiments some support is provided
for another potential mechanism of the effect of hypoglycemia on the heart.

Increases in plasma lactate and decreases

in pH -- both metabolic and respiratory in origin -- were
seen in hypoglycemic-clamped dogs even in the saline-inj acted grou.p.

Furthermore, hypoglycemia exaggerated the

development of endotoxic lactacidemia and acidosis (metabolic and respiratory).

It has been shown that hydrogen ions

adversely affect cardiac performance (162, 201).

However,

since there was no difference in the pH between the two unclamped endotoxic groups the impact of acidosis on cardiac
function and the contribution of hypoglycemia to that acidosis during endotoxin shock requires further investigation.
Central Nervous Svstem Depression
Since glucose is the major substrate of neural tissue
(46), regulation of cardiovascular and respiratory function
is deranged during hypoglycemic episodes.

The areas of the

brain which are most sensitive to glucose deprivation are
the neocortex and the centers involved in cardiovascular
and respiratory functions (46).

Himwich (83) describes a

progressive failure of the various regions of the brain
during hypoglycemia, starting from the neocortex and prograssing through the brain stem.

These stages are dependent

on the duration and degree of hypoglycemia.

During each
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stage there are different signs and symptoms which depend
on the level of consciousness and the prevailing autonomic
tone.

Gellhorn pointed to the autonomic imbalance produced

by the effects of hypoglycemia on the central nervous system

__ especially in conjunction with respiratory depression
leading to hypoxia and hypercapnia (63, 64, 65).

Randall

and coworkers (175, 176, 177, 210) have demonstrated the
role of autonomic imbalance in the development of cardiac
dysrhythmias using the technique of intrapericardial denervation.

It is also noteworthy that Gellhorn observed pe-

riodic breathing (Cheyne-Stokes respiration) in response
to hypoxia and hypoglycemia, but not in response to hypoglycemia alone (64).

Recently Raymond and Emerson (179)

studied the effects of hypoglycemia and diminished blood
flow on cerebral metabolism during endotoxin shock in dogs.
They concluded that the resulting depression of brainstem
cardiovascular and respiratory centers may be critical to
the pathogenesis of the shock state.
In addition to these effects on the central nervous
system it is also possible that hypoglycemia affects peripheral autonomic nerve function and cardiovascular reflex
mechanisms.

Miles and Hayter (155) discussed the role of

the baroreceptor reflex in the abnormal response to tilting
during insulin-induced hypoglycemia sometimes seen in diabetics.

While diabetic autonomic neuropathies may also be

a contributory factor in the failure of these patients to
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maintain blood pressure

o~

a tilt table after induction of

mild hypoglycemia, it is possible that under the more severe
hypoglycemia of endotoxin shock that the baroreceptor reflex
will nevertheless be attenuated by this mechanism.

Appen-

zeller has suggested that the sensitivity of the baroreceptors may be altered by insulin or glucose (2, 3, 24).

In

addition Jarhult and associates have demonstrated effects of
carotid baroreceptors on the function of pancreatic islets
as well as their more classical function in the cardiovascular system (111, 112).

It is conceivable that insulin

or glucose may feedback on the baroreceptors.

While the

evidence is largely speculative, hypoglycemia or hyperinsulinism might play a role in the resetting ·Of the baroreceptors during endotoxic hypotension.
Summary
There are, thus, several mechanisms by which hypoglycemia can lead to cardiovascular dyshomeostasis and
shock:

1) reticuloendothelial system depression, 2) altered

pulmonary vascular fluid balance, 3) increased pulmonary
vascular resistance, 4) altered vascular smooth muscle
function, 5) synergism with ischemia to produce myocardial
dysfunction, 6) acidosis leading to depression of cardiac
performance, and 7) altered neural regulation of the cardiovascular and respiratory systems.
are summarized in figure 19.

These hypotheses

None of these mechanisms is
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Fig. 19.

Hypothetical scheme of the role of
hypoglycemia in endotoxin shock
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mutually exclusive and it is possible -- even probable
that more than one or even all of them are involved.

The

evidence presented in this study indicates that the major
effect is most likely depression of myocardial performance
-- either directly or indirectly
pheral vasculature.

rather than the peri-

Further experiments are needed to look

more closely at cardiac performance during endotoxin shock
and to examine the different hypotheses for the mechanism
of hypoglycemic depression of the heart.

This is an import-

ant area since it opens up additional vistas linking metabolic homeostasis and cardiac function -- an area which
has largely been ignored.

CHAPTER VII
SUMMARY AND CONCLUSIONS
A canine model for the continuous monitoring of
blood glucose levels during endotoxic shock has been developed.

This model has been used to develop the technique

of glucose clamping at hypo-, norma-, and hyperglycemic
levels in order to study glucose metabolism during endotoxin shock and the relationship of derangements in glucose
homeostasis to the development of the collapse of the circulatory system.
Because of the use of continuous glucose monitoring,
it has been conclusively demonstrated that some dogs go
through an early hyperglycemic phase while others do not.
Previously, with the availability of only discontinuous
sampling, it was possible that the early hyperglycemic
phase was simply missed by the sampling rather than being
non-existent.

The mechanism regulating whether a hypergly-

cemic phase will occur is not known.

Regardless of whether

an animal showed early hyperglycemia or not following the
administration of endotoxin, a hyperinsulinemia with a
highly variable time course was seen to occur during endotoxin shock.

However, since in some cases spuriously high

insulin levels could be obtained because of the presence
of an interfering factor, the existence of hyperinsulinemia
147

148

in the endotoxic dog has not been conclusively demonstrated.
These results also have demonstrated that metabolic
failure leading to profound hypoglycemia following endotoxin injection is an important -- even critical -- factor
in the development of cardiovascular collapse while the initial hyperglycemia is a part of the compensatory mechanism
to prevent the circulatory failure and its lethal consequences.

The results are consistent with an effect of hypo-

glycemia to depress cardiac function in the endotoxic dog.
Further experiments are needed to determine the exact mechanism of the effects of hypoglycemia on cardiac performance.
The peripheral vasculature remains under neural control to
maintain blood pressure but this is accomplished at the tremendous cost of reflex vasoconstriction leading to tissue
ischemia.

The results also suggest that glucose dyshomeo-

stasis may also contribute to the increase in pulmonary resistance seen during endotoxin shock.

Such increases in

pulmonary resistance may contribute to the development of
cardiac failure.

Glucose clamping may be an effective

treatment for the circulatory sequelae of endotoxin shock.
Further refinements of the glucose clamping technique are
needed before the technique can be used in a treatment regimen to prevent the hypoglycemia and the resulting circulatory failure following endotoxin administration.
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Thus, in conclusion:
1)

The ability to maintain and even elevate
blood glucose levels is intimately associated with the ability to maintain cardiovascular function after endotoxin injection.

2)

Conversely, the development of metabolic
failure leading to profound, progressive
hypoglycemia is critically involved in
the circulatory collapse seen following
endotoxin administration.

3)

Hypoglycemia adversely affects cardiac
performance during endotoxicosis.

4)

Periphera·l vascular mechanisms are still
able to maintain blood pressure but at the
cost of tremendous increases in resistance
leading to tissue ischemia.

5)

Glucose clamping to maintain a hyperglycemic state may be an effective treatment regimen to prevent the circulatory
sequelae of endotoxin shock.
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6)

Further experimentation is needed to investigate the effect of the glucose dyshomeostasis of endotoxin shock on cardiac
performance.

7)

Further experimentation is also needed
to refine the glucose clamping technique for further studies of endotoxic
glucose metabolism in the dog and for
the development of an effective treatment to prevent the progression to
circulatory failure and shock.
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APPENDIX A

APPENDIX A
Additional Data Presentation
The following five figures show presentations of data
for selected parameters for individual dogs in the unclamped
groups (figures 20-23) and the average glucose levels during
the clamps in the glucose clamping groups (figure 24).

The

4 figures from the unclamped experiments demonstrate the
wide variability in the time course of endotoxin shock in
these sets of experiments and also show the two patterns of
blood glucose changes seen (figue 20).

Also seen in these

figures is the highly variable pattern of serum insulin (figure 21).

Figure 24 shows the average glucose levels during

the glucose. clamps.

Statistical analysis (a factorial ana-

lysis of variance) demonstrates that all three clamps were
different (P<0.05) with no differences between corresponding
endotoxin and saline groups (P>0.1),
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175

Fig. 20.

Glucose: Individual Dogs -- Unclamped
Experiments. Bottom=Endotoxin w/no
hyperglycemia, Middle=Endotoxin
w/hyperglycemia. Top=saline.
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Fig. 21.

Insulin: Individual Dogs -- Unclamped
Experiments. Bottom=Endotoxin w/no
hyperglycemia, Middle=Endotoxin
w/hyperglycemia, Top=saline.
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Fig. 22.

Cardiac Output: Individual Dogs -Unclamped Experiments. Bottom=
Endotoxin w/no hyperglycemia,
Middle=Endotoxin w/hyperglycemia,
Top=saline.
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Fig. 23.

Mean Systemic Arterial Pressure:
Individual Dogs -- Unclamped
Experiments. Bottom=Endotoxin
w/no hyperglycemia, Middle=
Endotoxin w/hyperglycemia,
Top=saline.
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Fig. 24.

Glucose Clamns:
~Endotoxin,
Hypoglycemic-Clamp (N=6);
#Saline, Hypoglycemic Clamp (N=5);
X Endotoxin, Normoglycemic Clamp (N=4);
0 Saline, Normoglycemic Clamp (N=J);
*Endotoxin, Hyperglycemic Clamp (N=4);
~Saline, Hyperglycemic Clamp (N=J).
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APPENDIX B

APPENDIX B
RIA PROGRAM
The following program, written in PFOCAL on PDP12
computer, was used to analyze the insulin data.

Data from

the gamma counter is read by the computer via paper tape.
The program consists of two parts:
and

1) the main program

2) the log-legit linear regression subroutine which is

accessed by the main program.
~

01.
01.
01.
01.
01.
01.
01.
01.
01 •

01
20
30
40
50
60
70
80

C
C
C
C
C
A
A

E1!

Program

RIA
CALCULATES RIA FROM DATA ENTERED INTO THE COMPUTER
VIA PAPER TAPE FROM GAMMA COUNTER
DEVELOPED BY P.M. KOBER AND M. R. YELICH
AUGUST 13, 1980
!!!"EXPERIMENT IDENTIFICATION #:"D
!!"NUMBER OF ASSAY TUBES?"N1

D 8

90 D 9

02. 05 S K=O
02. 10 T "itlELL # CPM(CH A)
B/BO
(K-1 ) 2. 2,2. 15
02. 15 T :53"IRI
AVG IRI"
o2. 20 T ! ; D 6
02. 30 T ! ! ! ! ! ; S K=1 ; D 2. 1 ; T
04.
04.
04.
04.
04.

10
20
27
30
40

C
0
S
F
Q

IRI CALCULATIONS ?OR SAHPLES
R I
K=);S S1=0;S I1=0
J=20,N1;D 5

05. 10 C SAMPLES
05. 20 A N, M, S, M, M, M
05. 30 S S2=S-BL;S S2=S2/H;S P(K)=S2
186

%B

AVG %B"I

187
05.
05.
05.
05.
05.

40 I
50 S
60S
70 0
75 T

05. 80 0
05. 90 S
05. 92 S
05. 94 0
05. 97 T
05. 98 S
05. 99 0

(K-1)5. 5,5. 9
S1=S1+S2;S K=i
I=FEXP(((FLOG(S2/(1-S2))-B)/Q)*FLOG(10));S I1=I1+I
I TTY
!,%4. OO,N, :9,%7 •. 01,5, :23,%4. 03,32, :31,%4. 01,.
100*52, :51%3. OO,I
R I; R
S1=(S1+S2)/2;S K=O
I=FEXP(((FLOG(S2/(1-S2))-B)/Q*FLOG(10));S I1=(I1+I)
/2
I TTY:
, :51,%3. 00, I, :59, I1; I (FABS(P(O)-P(1) )-. 05)5.
98,5. 98;T :62"*"
I1=0;S 51=0
R I;R

06. 10 C STANDARD CURVE CALCULATION
06. 20 0 I DF:RIA.FD
06. 30 F J=1,3;A M, M, M, M, M, M
06. 40 S K=O;S D1=0
06. 50 F J=4,19;D 7
06. 60 0 I TTY:,ECHO
06 70 L G STCURV
07.
07 •
07.
07.
07.
07.
07.

05 C STANDARDS
20
30
40
50
60

S
I
S
0
T

07.
07.
07.
07.

70
80
90
92

0
S
0
T

1 0 A N , M, S , M, t·! ,

~1

07. 94 S
07. 96 0

S=S-BL;S S(J)=S/H
(K-1)7. 4,7.8
S1=S1+S(J);S K=1
I TTY:
!,%4. OO,N, :9,%7. 01,S+BL, :23,%4. 03,S(J), :31,%4.
01,100*S(J)
R I;R
S1=(S1+S(J))/2;S K=O
I TTY:
!,%4. OO,N, :9,%7. 01,S+BL, :23,%4. 03,S(J), :31,
%4. 01,100*S(J), :40,31*100
S1=0
R I;R

08.
08.
08.
08.
08.
08.

10 C
20 0
30 F
40 0
50S
60 T

BLANK CALCULATION
I DF :RIA. FD
J=1,3;A M, M, X(J),M, M, M
I TTY:
BL=(X(2)+X(3))/2
!!!"CPM FOR BLANK+
"%6. 02,BL

09.
09.
09.
09.

10
20
30
40

STANDARD H CALCULATION (EO)
H=O
R I
J=4,19;D 10

C
S
0
F

188

09. 50 0 c
09. 60 S H=H/2-BL
09. 70 T !"CPM FOR SAMPLE H (BO)="H, !!!!!
10. 05 C STANDARD H
10. 10 A M,M,H1,M,M,M;I (J-18)10. 2;S H=H+H1
10. 20 R

189
Log-Legit Linear Regression
Subroutine
01. 10 C STCURV
01. 20 C LOG-LOGIT REGRESSION OF STANDARD CURVE FOR INSULIN
RIA
01. 30 C USED AS SUBROUTINE FOR RIA PROGRAM
01. 40 C DEVELOPED BY P. KOBER AND M. R. YELICH
01. 50 C AUGUST 13, 1980
01. 60S SX=O;S X2=0;S SY=);S Y2=0;S N2=14
01. 65 S D=193
01 • 67 T ! ! ! ! !
01. 70 F J=4,2,16;T !"STD DOSE ";S D=FOUT(D);A "?"S1;S S1(J)
=S1;S S1(J+1)=S1;S D
01. 80 F J=4,17;D 3
02.
02.
02.
02.
02.
02.
02.
02.

10 S DX=X2-SXA2/N2;S DY=Y2-SYA2/N2
20 S Q=(XY-SX*SY/N2)/DX;S B=(SY-SX*Q)/N2
30 S R=Q*DX/FSQT(DX*DY);S S=DY-QA2*DX;S E=FSQT(S/(N2-2))
40 T !!!!!%4. 03"LOGIT Y=",Q, "*LOG X+"%5. 03,B, "+/-"E
50 T !rrR="R
56 T !!
60 A "GOOD STANDARD CURVE?D;T !!!!!
70 I (D-OYES)4. 1 ;R

03. 10 S X=FLOG(S1(J))/FLOG(10);S Y=FLOG(S(J)/(1-S(J)))
03. 20 S SX=SX+X;S X2=X2+XA2;S SY=SY+Y;S Y2=Y2+YA2; XY=XY+
X*Y
04.
04.
04.
04.

10 A "HOW MANY BAD POINTS?"D
20 F G=1,D;D 5
25 S N2=N2-D
30 G 2. 1

05. 10 T "DOSE AND NUMBER OF BAD POINT"%3.00,G;A "?"S1,V
05. 20 S X=FLOG(S1)/FLOG(10);S Y=FLOG(S(V)/(!-S(V)))
05. 30 S SX=SX-X;S X2=X2-XA2;S SY=SY-Y;S Y2=Y2-A2;S
XY=XY-X*Y
*
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